KR20220108097A - Cured film forming composition, orientation material and retardation material - Google Patents
Cured film forming composition, orientation material and retardation material Download PDFInfo
- Publication number
- KR20220108097A KR20220108097A KR1020227021528A KR20227021528A KR20220108097A KR 20220108097 A KR20220108097 A KR 20220108097A KR 1020227021528 A KR1020227021528 A KR 1020227021528A KR 20227021528 A KR20227021528 A KR 20227021528A KR 20220108097 A KR20220108097 A KR 20220108097A
- Authority
- KR
- South Korea
- Prior art keywords
- component
- group
- cured film
- film formation
- formation composition
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims abstract description 73
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 239000000178 monomer Substances 0.000 claims abstract description 73
- 229920000642 polymer Polymers 0.000 claims abstract description 52
- -1 acrylamide compound Chemical class 0.000 claims abstract description 51
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 51
- 239000002904 solvent Substances 0.000 claims abstract description 46
- 150000001875 compounds Chemical class 0.000 claims abstract description 44
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 43
- 238000000034 method Methods 0.000 claims abstract description 33
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 29
- 125000003277 amino group Chemical group 0.000 claims abstract description 16
- 125000001424 substituent group Chemical group 0.000 claims abstract description 15
- 238000004132 cross linking Methods 0.000 claims abstract description 12
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 11
- 239000000194 fatty acid Substances 0.000 claims abstract description 11
- 229930195729 fatty acid Natural products 0.000 claims abstract description 11
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 11
- 239000003054 catalyst Substances 0.000 claims abstract description 10
- 125000005907 alkyl ester group Chemical group 0.000 claims abstract description 9
- 229920001477 hydrophilic polymer Polymers 0.000 claims abstract description 7
- 230000000379 polymerizing effect Effects 0.000 claims abstract description 6
- 229920000058 polyacrylate Polymers 0.000 claims description 29
- 125000004432 carbon atom Chemical group C* 0.000 claims description 25
- 229920005862 polyol Polymers 0.000 claims description 19
- 150000003077 polyols Chemical class 0.000 claims description 19
- 125000004185 ester group Chemical group 0.000 claims description 16
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 14
- 239000002202 Polyethylene glycol Substances 0.000 claims description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims description 11
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 9
- 229920002678 cellulose Polymers 0.000 claims description 8
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 7
- DMLAVOWQYNRWNQ-UHFFFAOYSA-N azobenzene Chemical group C1=CC=CC=C1N=NC1=CC=CC=C1 DMLAVOWQYNRWNQ-UHFFFAOYSA-N 0.000 claims description 7
- 229920000570 polyether Polymers 0.000 claims description 7
- 229920001610 polycaprolactone Polymers 0.000 claims description 6
- 239000004632 polycaprolactone Substances 0.000 claims description 6
- 229920000515 polycarbonate Polymers 0.000 claims description 6
- 239000004417 polycarbonate Substances 0.000 claims description 6
- 229920005906 polyester polyol Polymers 0.000 claims description 6
- 239000001913 cellulose Substances 0.000 claims description 5
- 125000000524 functional group Chemical group 0.000 claims description 4
- 239000004973 liquid crystal related substance Substances 0.000 abstract description 68
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 16
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 238000003860 storage Methods 0.000 abstract description 7
- 239000010408 film Substances 0.000 description 100
- 239000000243 solution Substances 0.000 description 23
- 238000002360 preparation method Methods 0.000 description 21
- 239000000758 substrate Substances 0.000 description 18
- 239000003795 chemical substances by application Substances 0.000 description 17
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 229920000858 Cyclodextrin Polymers 0.000 description 13
- 229920000877 Melamine resin Polymers 0.000 description 11
- 229920002284 Cellulose triacetate Polymers 0.000 description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 8
- 235000013824 polyphenols Nutrition 0.000 description 8
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 8
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 7
- 235000010980 cellulose Nutrition 0.000 description 7
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 6
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 6
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical group C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 6
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 5
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 5
- KBEBGUQPQBELIU-UHFFFAOYSA-N cinnamic acid ethyl ester Natural products CCOC(=O)C=CC1=CC=CC=C1 KBEBGUQPQBELIU-UHFFFAOYSA-N 0.000 description 5
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 4
- KBEBGUQPQBELIU-CMDGGOBGSA-N Ethyl cinnamate Chemical compound CCOC(=O)\C=C\C1=CC=CC=C1 KBEBGUQPQBELIU-CMDGGOBGSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 235000005513 chalcones Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 4
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- 230000001771 impaired effect Effects 0.000 description 4
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropyl acetate Chemical compound CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 4
- UTSYWKJYFPPRAP-UHFFFAOYSA-N n-(butoxymethyl)prop-2-enamide Chemical compound CCCCOCNC(=O)C=C UTSYWKJYFPPRAP-UHFFFAOYSA-N 0.000 description 4
- NBFNGRDFKUJVIN-VAWYXSNFSA-N phenyl (e)-3-phenylprop-2-enoate Chemical compound C=1C=CC=CC=1/C=C/C(=O)OC1=CC=CC=C1 NBFNGRDFKUJVIN-VAWYXSNFSA-N 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 230000010287 polarization Effects 0.000 description 4
- YKYONYBAUNKHLG-UHFFFAOYSA-N propyl acetate Chemical compound CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 3
- NXDILGARGPQYLL-UHFFFAOYSA-N 3-[4-(4-hydroxybutoxy)phenyl]prop-2-enoic acid Chemical compound OCCCCOC1=CC=C(C=CC(O)=O)C=C1 NXDILGARGPQYLL-UHFFFAOYSA-N 0.000 description 3
- OOUIOHASXNAAAE-UHFFFAOYSA-N 3-[4-(6-hydroxyhexoxy)phenyl]prop-2-enoic acid Chemical compound OCCCCCCOC1=CC=C(C=CC(O)=O)C=C1 OOUIOHASXNAAAE-UHFFFAOYSA-N 0.000 description 3
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 3
- 241000723347 Cinnamomum Species 0.000 description 3
- 239000001116 FEMA 4028 Substances 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 125000004103 aminoalkyl group Chemical group 0.000 description 3
- 229960004853 betadex Drugs 0.000 description 3
- 239000004305 biphenyl Substances 0.000 description 3
- 235000010290 biphenyl Nutrition 0.000 description 3
- 125000006267 biphenyl group Chemical group 0.000 description 3
- 235000017803 cinnamon Nutrition 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 125000005843 halogen group Chemical group 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 230000001678 irradiating effect Effects 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000012788 optical film Substances 0.000 description 3
- 238000000059 patterning Methods 0.000 description 3
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 3
- 238000011907 photodimerization Methods 0.000 description 3
- 239000003505 polymerization initiator Substances 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 229920001187 thermosetting polymer Polymers 0.000 description 3
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- JESXATFQYMPTNL-UHFFFAOYSA-N 2-ethenylphenol Chemical compound OC1=CC=CC=C1C=C JESXATFQYMPTNL-UHFFFAOYSA-N 0.000 description 2
- SVONRAPFKPVNKG-UHFFFAOYSA-N 2-ethoxyethyl acetate Chemical compound CCOCCOC(C)=O SVONRAPFKPVNKG-UHFFFAOYSA-N 0.000 description 2
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 2
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N 2-methoxyethyl acetate Chemical compound COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- SCJHPUGWYHCYAZ-UHFFFAOYSA-N 3,5-diethyl-2-propylpyridine Chemical compound CCCC1=NC=C(CC)C=C1CC SCJHPUGWYHCYAZ-UHFFFAOYSA-N 0.000 description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N 3-methyl-2-pentanone Chemical compound CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- NDWUBGAGUCISDV-UHFFFAOYSA-N 4-hydroxybutyl prop-2-enoate Chemical compound OCCCCOC(=O)C=C NDWUBGAGUCISDV-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- 229920003116 HPC-SSL Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- UJVHVMNGOZXSOZ-VKHMYHEASA-N L-BMAA Chemical compound CNC[C@H](N)C(O)=O UJVHVMNGOZXSOZ-VKHMYHEASA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 2
- NITWSHWHQAQBAW-UHFFFAOYSA-N MpCA Natural products COC(=O)C=CC1=CC=C(O)C=C1 NITWSHWHQAQBAW-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 229920004552 POLYLITE® Polymers 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- REUQOSNMSWLNPD-UHFFFAOYSA-N [2-(diethylamino)phenyl]-phenylmethanone Chemical compound CCN(CC)C1=CC=CC=C1C(=O)C1=CC=CC=C1 REUQOSNMSWLNPD-UHFFFAOYSA-N 0.000 description 2
- HVVWZTWDBSEWIH-UHFFFAOYSA-N [2-(hydroxymethyl)-3-prop-2-enoyloxy-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical compound C=CC(=O)OCC(CO)(COC(=O)C=C)COC(=O)C=C HVVWZTWDBSEWIH-UHFFFAOYSA-N 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 150000003926 acrylamides Chemical class 0.000 description 2
- 125000005396 acrylic acid ester group Chemical group 0.000 description 2
- 229920006243 acrylic copolymer Polymers 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000008366 benzophenones Chemical class 0.000 description 2
- 125000002529 biphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C12)* 0.000 description 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 2
- NMJJFJNHVMGPGM-UHFFFAOYSA-N butyl formate Chemical compound CCCCOC=O NMJJFJNHVMGPGM-UHFFFAOYSA-N 0.000 description 2
- ZOQCEVXVQCPESC-UHFFFAOYSA-N cis-p-coumaric acid ethyl ester Natural products CCOC(=O)C=CC1=CC=C(O)C=C1 ZOQCEVXVQCPESC-UHFFFAOYSA-N 0.000 description 2
- 229940097362 cyclodextrins Drugs 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 2
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- GJRQTCIYDGXPES-UHFFFAOYSA-N isobutyl acetate Chemical compound CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical group CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 2
- 125000005397 methacrylic acid ester group Chemical group 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 2
- 229940017219 methyl propionate Drugs 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920003986 novolac Polymers 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- YZOUYRAONFXZSI-SBHWVFSVSA-N (1S,3R,5R,6R,8R,10R,11R,13R,15R,16R,18R,20R,21R,23R,25R,26R,28R,30R,31S,33R,35R,36R,37S,38R,39S,40R,41S,42R,43S,44R,45S,46R,47S,48R,49S)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-37,39,40,41,42,43,44,45,46,47,48,49-dodecamethoxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,38-diol Chemical compound O([C@@H]([C@H]([C@@H]1OC)OC)O[C@H]2[C@@H](O)[C@@H]([C@@H](O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3O)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O3)O[C@@H]2CO)OC)[C@H](CO)[C@H]1O[C@@H]1[C@@H](OC)[C@H](OC)[C@H]3[C@@H](CO)O1 YZOUYRAONFXZSI-SBHWVFSVSA-N 0.000 description 1
- MCVVDMSWCQUKEV-UHFFFAOYSA-N (2-nitrophenyl)methyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCC1=CC=CC=C1[N+]([O-])=O MCVVDMSWCQUKEV-UHFFFAOYSA-N 0.000 description 1
- ZYMCBJWUWHHVRX-UHFFFAOYSA-N (4-nitrophenyl)-phenylmethanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)C1=CC=CC=C1 ZYMCBJWUWHHVRX-UHFFFAOYSA-N 0.000 description 1
- QXTKWWMLNUQOLB-UHFFFAOYSA-N (4-nitrophenyl)methyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCC1=CC=C([N+]([O-])=O)C=C1 QXTKWWMLNUQOLB-UHFFFAOYSA-N 0.000 description 1
- UHIXVKALQXFJCX-UHFFFAOYSA-N (4-phenyldiazenylphenoxy)methanol Chemical compound C1=CC(OCO)=CC=C1N=NC1=CC=CC=C1 UHIXVKALQXFJCX-UHFFFAOYSA-N 0.000 description 1
- ZISCOWXWCHUSMH-VOTSOKGWSA-N (E)-4-nitrostilbene Chemical compound C1=CC([N+](=O)[O-])=CC=C1\C=C\C1=CC=CC=C1 ZISCOWXWCHUSMH-VOTSOKGWSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- CQNPVMCASGWEHM-VMPITWQZSA-N (e)-3-[4-(dimethylamino)phenyl]prop-2-enoic acid Chemical compound CN(C)C1=CC=C(\C=C\C(O)=O)C=C1 CQNPVMCASGWEHM-VMPITWQZSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- GKNWQHIXXANPTN-UHFFFAOYSA-N 1,1,2,2,2-pentafluoroethanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)C(F)(F)F GKNWQHIXXANPTN-UHFFFAOYSA-N 0.000 description 1
- RJGUAQKOHAABLK-UHFFFAOYSA-N 1,1,2,2-tetrafluoro-2-(1,1,2,2,2-pentafluoroethoxy)ethanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)C(F)(F)OC(F)(F)C(F)(F)F RJGUAQKOHAABLK-UHFFFAOYSA-N 0.000 description 1
- UZVWXXJPPINTNL-UHFFFAOYSA-N 1-(4-methylphenyl)sulfonyloxyethyl 4-methylbenzenesulfonate Chemical compound C=1C=C(C)C=CC=1S(=O)(=O)OC(C)OS(=O)(=O)C1=CC=C(C)C=C1 UZVWXXJPPINTNL-UHFFFAOYSA-N 0.000 description 1
- DELTZPUKMVMMEZ-UHFFFAOYSA-N 1-[4-(2-hydroxyethoxy)phenyl]-3-phenylprop-2-en-1-one Chemical compound C1=CC(OCCO)=CC=C1C(=O)C=CC1=CC=CC=C1 DELTZPUKMVMMEZ-UHFFFAOYSA-N 0.000 description 1
- QARCICQMPUBHRD-UHFFFAOYSA-N 1-[4-(3-hydroxypropoxy)phenyl]-3-phenylprop-2-en-1-one Chemical compound C1=CC(OCCCO)=CC=C1C(=O)C=CC1=CC=CC=C1 QARCICQMPUBHRD-UHFFFAOYSA-N 0.000 description 1
- POMVFHSXSPOYSK-UHFFFAOYSA-N 1-[4-(4-hydroxybutoxy)phenyl]-3-phenylprop-2-en-1-one Chemical compound C1=CC(OCCCCO)=CC=C1C(=O)C=CC1=CC=CC=C1 POMVFHSXSPOYSK-UHFFFAOYSA-N 0.000 description 1
- KFXXHEXKMPXATK-UHFFFAOYSA-N 1-[4-(6-hydroxyhexoxy)phenyl]-3-phenylprop-2-en-1-one Chemical compound C1=CC(OCCCCCCO)=CC=C1C(=O)C=CC1=CC=CC=C1 KFXXHEXKMPXATK-UHFFFAOYSA-N 0.000 description 1
- GHGMIRUOAOHEBN-UHFFFAOYSA-N 1-[4-(8-hydroxyoctoxy)phenyl]-3-phenylprop-2-en-1-one Chemical compound OCCCCCCCCOc1ccc(cc1)C(=O)C=Cc1ccccc1 GHGMIRUOAOHEBN-UHFFFAOYSA-N 0.000 description 1
- QDNUKDGVQADNLW-UHFFFAOYSA-N 1-[4-(hydroxymethoxy)phenyl]-3-phenylprop-2-en-1-one Chemical compound C1=CC(OCO)=CC=C1C(=O)C=CC1=CC=CC=C1 QDNUKDGVQADNLW-UHFFFAOYSA-N 0.000 description 1
- BQTPKSBXMONSJI-UHFFFAOYSA-N 1-cyclohexylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1CCCCC1 BQTPKSBXMONSJI-UHFFFAOYSA-N 0.000 description 1
- HIDBROSJWZYGSZ-UHFFFAOYSA-N 1-phenylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=CC=C1 HIDBROSJWZYGSZ-UHFFFAOYSA-N 0.000 description 1
- DMFAHCVITRDZQB-UHFFFAOYSA-N 1-propoxypropan-2-yl acetate Chemical compound CCCOCC(C)OC(C)=O DMFAHCVITRDZQB-UHFFFAOYSA-N 0.000 description 1
- IGKCQDUYZULGBM-UHFFFAOYSA-N 2,2,2-trifluoroethyl 4-methylbenzenesulfonate Chemical compound CC1=CC=C(S(=O)(=O)OCC(F)(F)F)C=C1 IGKCQDUYZULGBM-UHFFFAOYSA-N 0.000 description 1
- LXFQSRIDYRFTJW-UHFFFAOYSA-N 2,4,6-trimethylbenzenesulfonic acid Chemical compound CC1=CC(C)=C(S(O)(=O)=O)C(C)=C1 LXFQSRIDYRFTJW-UHFFFAOYSA-N 0.000 description 1
- IRLYGRLEBKCYPY-UHFFFAOYSA-N 2,5-dimethylbenzenesulfonic acid Chemical compound CC1=CC=C(C)C(S(O)(=O)=O)=C1 IRLYGRLEBKCYPY-UHFFFAOYSA-N 0.000 description 1
- 150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
- BRETYAHLENMEAI-UHFFFAOYSA-N 2,6-dimethylbenzenesulfonic acid Chemical compound CC1=CC=CC(C)=C1S(O)(=O)=O BRETYAHLENMEAI-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- FGWFAOSIYITUME-UHFFFAOYSA-N 2-(4-methylphenyl)sulfonyloxypropan-2-yl 4-methylbenzenesulfonate Chemical compound S(=O)(=O)(C1=CC=C(C)C=C1)OC(C)(C)OS(=O)(=O)C1=CC=C(C)C=C1 FGWFAOSIYITUME-UHFFFAOYSA-N 0.000 description 1
- DIZBQMTZXOUFTD-UHFFFAOYSA-N 2-(furan-2-yl)-3h-benzimidazole-5-carboxylic acid Chemical compound N1C2=CC(C(=O)O)=CC=C2N=C1C1=CC=CO1 DIZBQMTZXOUFTD-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- DHELLYXEESJYNP-UHFFFAOYSA-N 2-[(3-aminophenyl)methylidene]butanoic acid Chemical compound CCC(C(O)=O)=CC1=CC=CC(N)=C1 DHELLYXEESJYNP-UHFFFAOYSA-N 0.000 description 1
- YYQXUJDILPJIFL-UHFFFAOYSA-N 2-[(4-aminophenyl)methylidene]butanoic acid Chemical compound CCC(C(O)=O)=CC1=CC=C(N)C=C1 YYQXUJDILPJIFL-UHFFFAOYSA-N 0.000 description 1
- CCJAYIGMMRQRAO-UHFFFAOYSA-N 2-[4-[(2-hydroxyphenyl)methylideneamino]butyliminomethyl]phenol Chemical compound OC1=CC=CC=C1C=NCCCCN=CC1=CC=CC=C1O CCJAYIGMMRQRAO-UHFFFAOYSA-N 0.000 description 1
- FDSUVTROAWLVJA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol;prop-2-enoic acid Chemical compound OC(=O)C=C.OC(=O)C=C.OC(=O)C=C.OC(=O)C=C.OC(=O)C=C.OCC(CO)(CO)COCC(CO)(CO)CO FDSUVTROAWLVJA-UHFFFAOYSA-N 0.000 description 1
- QLIBJPGWWSHWBF-UHFFFAOYSA-N 2-aminoethyl methacrylate Chemical compound CC(=C)C(=O)OCCN QLIBJPGWWSHWBF-UHFFFAOYSA-N 0.000 description 1
- UGIJCMNGQCUTPI-UHFFFAOYSA-N 2-aminoethyl prop-2-enoate Chemical compound NCCOC(=O)C=C UGIJCMNGQCUTPI-UHFFFAOYSA-N 0.000 description 1
- XUDBVJCTLZTSDC-UHFFFAOYSA-N 2-ethenylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C=C XUDBVJCTLZTSDC-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- IEVADDDOVGMCSI-UHFFFAOYSA-N 2-hydroxybutyl 2-methylprop-2-enoate Chemical compound CCC(O)COC(=O)C(C)=C IEVADDDOVGMCSI-UHFFFAOYSA-N 0.000 description 1
- UVSOURZMHXZMJW-UHFFFAOYSA-N 2-hydroxybutyl 4-methylbenzenesulfonate Chemical compound CCC(O)COS(=O)(=O)C1=CC=C(C)C=C1 UVSOURZMHXZMJW-UHFFFAOYSA-N 0.000 description 1
- WYOVFOGJDRFZBX-UHFFFAOYSA-N 2-hydroxyethyl 3-phenylprop-2-enoate Chemical compound OCCOC(=O)C=CC1=CC=CC=C1 WYOVFOGJDRFZBX-UHFFFAOYSA-N 0.000 description 1
- GWZMWHWAWHPNHN-UHFFFAOYSA-N 2-hydroxypropyl prop-2-enoate Chemical compound CC(O)COC(=O)C=C GWZMWHWAWHPNHN-UHFFFAOYSA-N 0.000 description 1
- LWRBVKNFOYUCNP-UHFFFAOYSA-N 2-methyl-1-(4-methylsulfanylphenyl)-2-morpholin-4-ylpropan-1-one Chemical compound C1=CC(SC)=CC=C1C(=O)C(C)(C)N1CCOCC1 LWRBVKNFOYUCNP-UHFFFAOYSA-N 0.000 description 1
- RUMACXVDVNRZJZ-UHFFFAOYSA-N 2-methylpropyl 2-methylprop-2-enoate Chemical compound CC(C)COC(=O)C(C)=C RUMACXVDVNRZJZ-UHFFFAOYSA-N 0.000 description 1
- QIMRPGAQCKHRKB-UHFFFAOYSA-N 2-methylpropyl 4-methylbenzenesulfonate Chemical compound CC(C)COS(=O)(=O)C1=CC=C(C)C=C1 QIMRPGAQCKHRKB-UHFFFAOYSA-N 0.000 description 1
- CFVWNXQPGQOHRJ-UHFFFAOYSA-N 2-methylpropyl prop-2-enoate Chemical compound CC(C)COC(=O)C=C CFVWNXQPGQOHRJ-UHFFFAOYSA-N 0.000 description 1
- AJEAHBZZHSLIQP-UHFFFAOYSA-N 2-nitrofluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC([N+](=O)[O-])=CC=C3C2=C1 AJEAHBZZHSLIQP-UHFFFAOYSA-N 0.000 description 1
- XFOHWECQTFIEIX-UHFFFAOYSA-N 2-nitrofluorene Chemical compound C1=CC=C2C3=CC=C([N+](=O)[O-])C=C3CC2=C1 XFOHWECQTFIEIX-UHFFFAOYSA-N 0.000 description 1
- ACMLKANOGIVEPB-UHFFFAOYSA-N 2-oxo-2H-chromene-3-carboxylic acid Chemical compound C1=CC=C2OC(=O)C(C(=O)O)=CC2=C1 ACMLKANOGIVEPB-UHFFFAOYSA-N 0.000 description 1
- CVPPUZPZPFOFPK-UHFFFAOYSA-N 2-phenylethyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCCC1=CC=CC=C1 CVPPUZPZPFOFPK-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- VIONGDJUYAYOPU-UHFFFAOYSA-N 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctane-1-sulfonic acid Chemical compound OS(=O)(=O)CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F VIONGDJUYAYOPU-UHFFFAOYSA-N 0.000 description 1
- HJBWJAPEBGSQPR-GQCTYLIASA-N 3,4-dimethoxycinnamic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1OC HJBWJAPEBGSQPR-GQCTYLIASA-N 0.000 description 1
- WCPNDHITXVUFFM-UHFFFAOYSA-N 3-(3-aminophenyl)-2-methylprop-2-enoic acid Chemical compound OC(=O)C(C)=CC1=CC=CC(N)=C1 WCPNDHITXVUFFM-UHFFFAOYSA-N 0.000 description 1
- MUYUDVPKJZCBOA-UHFFFAOYSA-N 3-(4-aminophenyl)-2-methylprop-2-enoic acid Chemical compound OC(=O)C(C)=CC1=CC=C(N)C=C1 MUYUDVPKJZCBOA-UHFFFAOYSA-N 0.000 description 1
- LZXOBQXLOPBWFS-UHFFFAOYSA-N 3-(4-hydroxy-2-methoxyphenyl)-1-phenylprop-2-en-1-one Chemical compound COC1=C(C=CC(=C1)O)C=CC(=O)C1=CC=CC=C1 LZXOBQXLOPBWFS-UHFFFAOYSA-N 0.000 description 1
- MFRBMNNZDFDJOF-UHFFFAOYSA-N 3-(4-methylphenyl)sulfonyloxybutan-2-yl 4-methylbenzenesulfonate Chemical compound C=1C=C(C)C=CC=1S(=O)(=O)OC(C)C(C)OS(=O)(=O)C1=CC=C(C)C=C1 MFRBMNNZDFDJOF-UHFFFAOYSA-N 0.000 description 1
- CZAYTOJEWGACON-UHFFFAOYSA-N 3-(4-phenyldiazenylphenoxy)propan-1-ol Chemical compound C1=CC(OCCCO)=CC=C1N=NC1=CC=CC=C1 CZAYTOJEWGACON-UHFFFAOYSA-N 0.000 description 1
- PJGURSHKYXDWTG-UHFFFAOYSA-N 3-(6-hydroxyhexoxy)chromen-2-one Chemical compound C1=CC=C2OC(=O)C(OCCCCCCO)=CC2=C1 PJGURSHKYXDWTG-UHFFFAOYSA-N 0.000 description 1
- HZVWBJIQESFDDU-UHFFFAOYSA-N 3-(6-hydroxyoctoxy)chromen-2-one Chemical compound C1=CC=C2OC(=O)C(OCCCCCC(O)CC)=CC2=C1 HZVWBJIQESFDDU-UHFFFAOYSA-N 0.000 description 1
- LGMSEQAVPZEVRC-UHFFFAOYSA-N 3-[4-(3-hydroxypropoxy)phenyl]-1-phenylprop-2-en-1-one Chemical compound C1=CC(OCCCO)=CC=C1C=CC(=O)C1=CC=CC=C1 LGMSEQAVPZEVRC-UHFFFAOYSA-N 0.000 description 1
- SNCMCDMEYCLVBO-UHFFFAOYSA-N 3-aminopropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCN SNCMCDMEYCLVBO-UHFFFAOYSA-N 0.000 description 1
- OTKLRHWBZHQJOP-UHFFFAOYSA-N 3-aminopropyl prop-2-enoate Chemical compound NCCCOC(=O)C=C OTKLRHWBZHQJOP-UHFFFAOYSA-N 0.000 description 1
- YNGIFMKMDRDNBQ-UHFFFAOYSA-N 3-ethenylphenol Chemical compound OC1=CC=CC(C=C)=C1 YNGIFMKMDRDNBQ-UHFFFAOYSA-N 0.000 description 1
- WMLPCVWBTMBRIN-UHFFFAOYSA-N 3-hydroxypropyl 3-phenylprop-2-enoate Chemical compound OCCCOC(=O)C=CC1=CC=CC=C1 WMLPCVWBTMBRIN-UHFFFAOYSA-N 0.000 description 1
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 description 1
- UAHGNXFYLAJDIN-UHFFFAOYSA-N 4'-Hydroxychalcone Natural products C1=CC(O)=CC=C1C(=O)C=CC1=CC=CC=C1 UAHGNXFYLAJDIN-UHFFFAOYSA-N 0.000 description 1
- UAHGNXFYLAJDIN-IZZDOVSWSA-N 4'-hydroxychalcone Chemical compound C1=CC(O)=CC=C1C(=O)\C=C\C1=CC=CC=C1 UAHGNXFYLAJDIN-IZZDOVSWSA-N 0.000 description 1
- ZAWBNFXIMMLMKK-UHFFFAOYSA-N 4-(4-phenyldiazenylphenoxy)butan-1-ol Chemical compound C1=CC(OCCCCO)=CC=C1N=NC1=CC=CC=C1 ZAWBNFXIMMLMKK-UHFFFAOYSA-N 0.000 description 1
- BEYOBVMPDRKTNR-BUHFOSPRSA-N 4-Hydroxyazobenzene Chemical compound C1=CC(O)=CC=C1\N=N\C1=CC=CC=C1 BEYOBVMPDRKTNR-BUHFOSPRSA-N 0.000 description 1
- BAJQRLZAPXASRD-UHFFFAOYSA-N 4-Nitrobiphenyl Chemical group C1=CC([N+](=O)[O-])=CC=C1C1=CC=CC=C1 BAJQRLZAPXASRD-UHFFFAOYSA-N 0.000 description 1
- BRIXOPDYGQCZFO-UHFFFAOYSA-N 4-ethylphenylsulfonic acid Chemical compound CCC1=CC=C(S(O)(=O)=O)C=C1 BRIXOPDYGQCZFO-UHFFFAOYSA-N 0.000 description 1
- YKXAYLPDMSGWEV-UHFFFAOYSA-N 4-hydroxybutyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCO YKXAYLPDMSGWEV-UHFFFAOYSA-N 0.000 description 1
- IXDKVVOXGHKNCK-UHFFFAOYSA-N 4-hydroxybutyl 3-phenylprop-2-enoate Chemical compound OCCCCOC(=O)C=CC1=CC=CC=C1 IXDKVVOXGHKNCK-UHFFFAOYSA-N 0.000 description 1
- PWWCDTYUYPOAIU-DHZHZOJOSA-N 4-hydroxychalcone Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=CC=C1 PWWCDTYUYPOAIU-DHZHZOJOSA-N 0.000 description 1
- FUGYGGDSWSUORM-UHFFFAOYSA-N 4-hydroxystyrene Chemical compound OC1=CC=C(C=C)C=C1 FUGYGGDSWSUORM-UHFFFAOYSA-N 0.000 description 1
- ZYUVGYBAPZYKSA-UHFFFAOYSA-N 5-(3-hydroxybutan-2-yl)-4-methylbenzene-1,3-diol Chemical compound CC(O)C(C)C1=CC(O)=CC(O)=C1C ZYUVGYBAPZYKSA-UHFFFAOYSA-N 0.000 description 1
- CUARLQDWYSRQDF-UHFFFAOYSA-N 5-Nitroacenaphthene Chemical compound C1CC2=CC=CC3=C2C1=CC=C3[N+](=O)[O-] CUARLQDWYSRQDF-UHFFFAOYSA-N 0.000 description 1
- YGTVWCBFJAVSMS-UHFFFAOYSA-N 5-hydroxypentyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCO YGTVWCBFJAVSMS-UHFFFAOYSA-N 0.000 description 1
- INRQKLGGIVSJRR-UHFFFAOYSA-N 5-hydroxypentyl prop-2-enoate Chemical compound OCCCCCOC(=O)C=C INRQKLGGIVSJRR-UHFFFAOYSA-N 0.000 description 1
- OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 1
- XZXJLWBEYJZHSI-UHFFFAOYSA-N 6-(4-hydroxybutoxy)chromen-2-one Chemical compound O1C(=O)C=CC2=CC(OCCCCO)=CC=C21 XZXJLWBEYJZHSI-UHFFFAOYSA-N 0.000 description 1
- XCDFVECGUGAXBT-UHFFFAOYSA-N 6-hydroxyhexyl 3-phenylprop-2-enoate Chemical compound OCCCCCCOC(=O)C=CC1=CC=CC=C1 XCDFVECGUGAXBT-UHFFFAOYSA-N 0.000 description 1
- QQYKFCKZDLUGBK-UHFFFAOYSA-N 7-(3-hydroxypropoxy)chromen-2-one Chemical compound C1=CC(=O)OC2=CC(OCCCO)=CC=C21 QQYKFCKZDLUGBK-UHFFFAOYSA-N 0.000 description 1
- XIZUVLKSJHIXEK-UHFFFAOYSA-N 7-(4-hydroxybutoxy)chromen-2-one Chemical compound C1=CC(=O)OC2=CC(OCCCCO)=CC=C21 XIZUVLKSJHIXEK-UHFFFAOYSA-N 0.000 description 1
- AFUTZQHENQBVIE-UHFFFAOYSA-N 7-(6-hydroxyhexoxy)chromen-2-one Chemical compound C1=CC(=O)OC2=CC(OCCCCCCO)=CC=C21 AFUTZQHENQBVIE-UHFFFAOYSA-N 0.000 description 1
- UCQKETFDIUYJCV-UHFFFAOYSA-N 7-(hydroxymethoxy)chromen-2-one Chemical compound C1=CC(=O)OC2=CC(OCO)=CC=C21 UCQKETFDIUYJCV-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- HJBWJAPEBGSQPR-UHFFFAOYSA-N DMCA Natural products COC1=CC=C(C=CC(O)=O)C=C1OC HJBWJAPEBGSQPR-UHFFFAOYSA-N 0.000 description 1
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 1
- 101150096839 Fcmr gene Proteins 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- NITWSHWHQAQBAW-QPJJXVBHSA-N Methyl 4-hydroxy cinnamate Natural products COC(=O)\C=C\C1=CC=C(O)C=C1 NITWSHWHQAQBAW-QPJJXVBHSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- 241000047703 Nonion Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- BXFNEJKZNACMPY-UHFFFAOYSA-N OCCCCCCCCOC(=O)C=Cc1ccccc1 Chemical compound OCCCCCCCCOC(=O)C=Cc1ccccc1 BXFNEJKZNACMPY-UHFFFAOYSA-N 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- KFNNIILCVOLYIR-UHFFFAOYSA-N Propyl formate Chemical compound CCCOC=O KFNNIILCVOLYIR-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000004849 alkoxymethyl group Chemical group 0.000 description 1
- 125000005370 alkoxysilyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 125000005577 anthracene group Chemical group 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- AOJOEFVRHOZDFN-UHFFFAOYSA-N benzyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1=CC=CC=C1 AOJOEFVRHOZDFN-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 1
- QDHFHIQKOVNCNC-UHFFFAOYSA-N butane-1-sulfonic acid Chemical compound CCCCS(O)(=O)=O QDHFHIQKOVNCNC-UHFFFAOYSA-N 0.000 description 1
- 239000001191 butyl (2R)-2-hydroxypropanoate Substances 0.000 description 1
- QYJXDIUNDMRLAO-UHFFFAOYSA-N butyl 4-methylbenzenesulfonate Chemical compound CCCCOS(=O)(=O)C1=CC=C(C)C=C1 QYJXDIUNDMRLAO-UHFFFAOYSA-N 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- BTMVHUNTONAYDX-UHFFFAOYSA-N butyl propionate Chemical compound CCCCOC(=O)CC BTMVHUNTONAYDX-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000003098 cholesteric effect Effects 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 125000000332 coumarinyl group Chemical group O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
- PFXOLUYGXYEFOR-UHFFFAOYSA-N cyanomethyl 4-methylbenzenesulfonate Chemical compound CC1=CC=C(S(=O)(=O)OCC#N)C=C1 PFXOLUYGXYEFOR-UHFFFAOYSA-N 0.000 description 1
- 229920005565 cyclic polymer Polymers 0.000 description 1
- NHADDZMCASKINP-HTRCEHHLSA-N decarboxydihydrocitrinin Natural products C1=C(O)C(C)=C2[C@H](C)[C@@H](C)OCC2=C1O NHADDZMCASKINP-HTRCEHHLSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229940075894 denatured ethanol Drugs 0.000 description 1
- 229960004132 diethyl ether Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- ROORDVPLFPIABK-UHFFFAOYSA-N diphenyl carbonate Chemical compound C=1C=CC=CC=1OC(=O)OC1=CC=CC=C1 ROORDVPLFPIABK-UHFFFAOYSA-N 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- ZANNOFHADGWOLI-UHFFFAOYSA-N ethyl 2-hydroxyacetate Chemical compound CCOC(=O)CO ZANNOFHADGWOLI-UHFFFAOYSA-N 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- BHXIWUJLHYHGSJ-UHFFFAOYSA-N ethyl 3-ethoxypropanoate Chemical compound CCOCCC(=O)OCC BHXIWUJLHYHGSJ-UHFFFAOYSA-N 0.000 description 1
- IJUHLFUALMUWOM-UHFFFAOYSA-N ethyl 3-methoxypropanoate Chemical compound CCOC(=O)CCOC IJUHLFUALMUWOM-UHFFFAOYSA-N 0.000 description 1
- VRZVPALEJCLXPR-UHFFFAOYSA-N ethyl 4-methylbenzenesulfonate Chemical compound CCOS(=O)(=O)C1=CC=C(C)C=C1 VRZVPALEJCLXPR-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 description 1
- 229940117360 ethyl pyruvate Drugs 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- SLGWESQGEUXWJQ-UHFFFAOYSA-N formaldehyde;phenol Chemical compound O=C.OC1=CC=CC=C1 SLGWESQGEUXWJQ-UHFFFAOYSA-N 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229920013819 hydroxyethyl ethylcellulose Polymers 0.000 description 1
- DWFYUYGUKCLXHB-UHFFFAOYSA-N hydroxymethyl 3-phenylprop-2-enoate Chemical compound OCOC(=O)C=CC1=CC=CC=C1 DWFYUYGUKCLXHB-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000005641 methacryl group Chemical group 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- HSDFKDZBJMDHFF-UHFFFAOYSA-N methyl 3-ethoxypropanoate Chemical compound CCOCCC(=O)OC HSDFKDZBJMDHFF-UHFFFAOYSA-N 0.000 description 1
- BDJSOPWXYLFTNW-UHFFFAOYSA-N methyl 3-methoxypropanoate Chemical compound COCCC(=O)OC BDJSOPWXYLFTNW-UHFFFAOYSA-N 0.000 description 1
- VUQUOGPMUUJORT-UHFFFAOYSA-N methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1 VUQUOGPMUUJORT-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- CWKLZLBVOJRSOM-UHFFFAOYSA-N methyl pyruvate Chemical compound COC(=O)C(C)=O CWKLZLBVOJRSOM-UHFFFAOYSA-N 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- YGRMNBNGHHDGCX-UHFFFAOYSA-N n-(ethoxymethyl)-2-methylprop-2-enamide Chemical compound CCOCNC(=O)C(C)=C YGRMNBNGHHDGCX-UHFFFAOYSA-N 0.000 description 1
- OHPZPBNDOVQJMH-UHFFFAOYSA-N n-ethyl-4-methylbenzenesulfonamide Chemical compound CCNS(=O)(=O)C1=CC=C(C)C=C1 OHPZPBNDOVQJMH-UHFFFAOYSA-N 0.000 description 1
- SEEYREPSKCQBBF-UHFFFAOYSA-N n-methylmaleimide Chemical compound CN1C(=O)C=CC1=O SEEYREPSKCQBBF-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- WLGDAKIJYPIYLR-UHFFFAOYSA-N octane-1-sulfonic acid Chemical compound CCCCCCCCS(O)(=O)=O WLGDAKIJYPIYLR-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- RJQRCOMHVBLQIH-UHFFFAOYSA-M pentane-1-sulfonate Chemical compound CCCCCS([O-])(=O)=O RJQRCOMHVBLQIH-UHFFFAOYSA-M 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- JGTNAGYHADQMCM-UHFFFAOYSA-N perfluorobutanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F JGTNAGYHADQMCM-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- XJGDWYSZZPUQSL-UHFFFAOYSA-N phenyl 3-(4-hydroxyphenyl)prop-2-enoate Chemical compound C1=CC(O)=CC=C1C=CC(=O)OC1=CC=CC=C1 XJGDWYSZZPUQSL-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000083 poly(allylamine) Polymers 0.000 description 1
- 229920005575 poly(amic acid) Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 239000009719 polyimide resin Substances 0.000 description 1
- 239000002685 polymerization catalyst Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BOQSSGDQNWEFSX-UHFFFAOYSA-N propan-2-yl 2-methylprop-2-enoate Chemical compound CC(C)OC(=O)C(C)=C BOQSSGDQNWEFSX-UHFFFAOYSA-N 0.000 description 1
- LYBIZMNPXTXVMV-UHFFFAOYSA-N propan-2-yl prop-2-enoate Chemical compound CC(C)OC(=O)C=C LYBIZMNPXTXVMV-UHFFFAOYSA-N 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- JTTWNTXHFYNETH-UHFFFAOYSA-N propyl 4-methylbenzenesulfonate Chemical compound CCCOS(=O)(=O)C1=CC=C(C)C=C1 JTTWNTXHFYNETH-UHFFFAOYSA-N 0.000 description 1
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011342 resin composition Substances 0.000 description 1
- 239000006254 rheological additive Substances 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical group C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 150000003440 styrenes Chemical class 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- SJMYWORNLPSJQO-UHFFFAOYSA-N tert-butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)(C)C SJMYWORNLPSJQO-UHFFFAOYSA-N 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- C08L33/24—Homopolymers or copolymers of amides or imides
- C08L33/26—Homopolymers or copolymers of acrylamide or methacrylamide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L101/00—Compositions of unspecified macromolecular compounds
- C08L101/02—Compositions of unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B5/00—Optical elements other than lenses
- G02B5/30—Polarising elements
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1335—Structural association of cells with optical devices, e.g. polarisers or reflectors
- G02F1/13363—Birefringent elements, e.g. for optical compensation
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Nonlinear Science (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mathematical Physics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Liquid Crystal (AREA)
Abstract
[과제] 우수한 배향감도를 가지며, 배향성도 우수하고, TAC필름과의 밀착성도 우수한 배향재를 부여함과 함께, 보존안정성이 향상된 경화막 형성 조성물을 제공한다.
[해결수단] 경화막 형성 조성물은, (A)광배향성기와 하이드록시기, 카르복실기 및 아미노기로부터 선택되는 어느 1개의 치환기를 갖는 화합물, (B)하이드록시기, 카르복실기 및 아미노기로부터 선택되는 1종 또는 2종 이상의 치환기를 갖는 친수성 폴리머, (C)N-하이드록시메틸 화합물 또는 N-알콕시메틸(메트)아크릴아미드 화합물을 포함하는 모노머를 중합한 폴리머, (D)가교촉매, 그리고, 탄소수 1~5의 알코올과, 탄소수 1~4의 지방산의 탄소수 1~4알킬에스테르와의 쌍방을 포함하는 용제를 함유한다. 이 경화막 형성 조성물을 이용하여, 경화막을 형성하고, 광배향기술을 이용하여 배향재를 형성한다. 배향재의 위에 중합성 액정을 도포하고, 경화시켜 위상차재를 얻는다.[Problem] To provide a cured film-forming composition having excellent orientation sensitivity, excellent orientation, and providing an orientation material having excellent adhesion to a TAC film, and improved storage stability.
[Solutions] The cured film forming composition is (A) a compound having any one substituent selected from a photo-alignment group, a hydroxyl group, a carboxyl group, and an amino group, (B) a hydroxyl group, a carboxyl group, and an amino group. A hydrophilic polymer having two or more substituents, (C) a polymer obtained by polymerizing a monomer containing a N-hydroxymethyl compound or an N-alkoxymethyl (meth)acrylamide compound, (D) a crosslinking catalyst, and a C1 to C5 The solvent containing both the alcohol of and the C1-C4 alkylester of a C1-C4 fatty acid is contained. A cured film is formed using this cured film formation composition, and an orientation material is formed using the photo-alignment technique. A polymeric liquid crystal is apply|coated on the orientation material, it is made to harden|cure, and retardation material is obtained.
Description
본 발명은, 경화막 형성 조성물, 배향재 및 위상차재에 관한 것이다.The present invention relates to a cured film forming composition, an orientation material, and a retardation material.
원편광 안경방식의 3D디스플레이의 경우, 액정패널 등의 화상을 형성하는 표시소자의 위에 위상차재가 배치되는 것이 통상이다. 이 위상차재는, 위상차특성이 상이한 2종류의 위상차영역이 각각 복수, 규칙적으로 배치되어 있고, 패터닝된 위상차재를 구성하고 있다. 한편, 이하, 본 명세서에 있어서는, 이러한 위상차특성이 상이한 복수의 위상차영역을 배치하도록 패턴화된 위상차재를 패턴화 위상차재라 칭한다.In the case of a circularly polarized glasses type 3D display, a phase difference material is usually disposed on a display element that forms an image such as a liquid crystal panel. In this phase difference material, two types of phase difference areas from which phase difference characteristics differ are respectively arrange|positioned regularly and plural, respectively, and comprise the patterned phase difference material. On the other hand, hereinafter, in the present specification, the phase difference material patterned so as to arrange a plurality of phase difference regions having different phase difference characteristics is referred to as a patterned phase difference material.
패턴화 위상차재는, 예를 들어, 특허문헌 1에 개시되는 바와 같이, 중합성 액정으로 이루어지는 위상차재료를 광학패터닝함으로써 제작할 수 있다. 중합성 액정으로 이루어지는 위상차재료의 광학패터닝은, 액정패널의 배향재 형성에서 알려진 광배향기술을 이용한다. 즉, 기판 상에 광배향성의 재료로 이루어지는 도막을 마련하고, 이것에 편광방향이 상이한 2종류의 편광을 조사한다. 그리고, 액정의 배향제어방향이 상이한 2종류의 액정배향영역이 형성된 배향재로서 광배향막을 얻는다. 이 광배향막의 위에 중합성 액정을 포함하는 용액상의 위상차재료를 도포하여, 중합성 액정의 배향을 실현한다. 그 후, 배향된 중합성 액정을 경화하여 패턴화 위상차재를 형성한다.A patterned retardation material can be produced by optically patterning the retardation material which consists of a polymeric liquid crystal, as disclosed by patent document 1, for example. The optical patterning of the retardation material made of polymerizable liquid crystal uses a photo-alignment technique known in the formation of an alignment material of a liquid crystal panel. That is, a coating film made of a material having a photo-alignment property is provided on a substrate, and two types of polarized light having different polarization directions are irradiated thereon. And a photo-alignment film is obtained as an orientation material in which two types of liquid-crystal orientation regions from which the orientation control direction of a liquid crystal differ are formed. A solution phase difference material containing a polymerizable liquid crystal is applied on the photo-alignment film to achieve alignment of the polymerizable liquid crystal. Thereafter, the aligned polymerizable liquid crystal is cured to form a patterned retardation material.
유기EL디스플레이의 반사방지막은, 직선편광판, 1/4파장위상차판에 의해 구성되며, 화상표시패널의 패널면을 향하는 외래광을 직선편광판에 의해 직선편광으로 변환하고, 이어지는 1/4파장위상차판에 의해 원편광으로 변환한다. 여기서 이 원편광에 의한 외래광은, 화상표시패널의 표면 등에서 반사되나, 이 반사시에 편광면의 회전방향이 역전한다. 그 결과, 이 반사광은, 도래시와는 반대로, 1/4파장위상차판으로부터, 직선편광판에 의해 차광되는 방향의 직선편광으로 변환된 후, 이어지는 직선편광판에 의해 차광되고, 그 결과, 외부에의 출사가 현저히 억제된다.The antireflection film of the organic EL display is composed of a linear polarizer and a quarter-wave retardation plate, and the extraneous light directed toward the panel surface of the image display panel is converted into linearly polarized light by the linear polarizer, followed by a quarter-wave retardation plate converted to circular polarization by Here, the extraneous light by the circularly polarized light is reflected on the surface of the image display panel or the like, but the rotational direction of the polarization plane is reversed at the time of this reflection. As a result, the reflected light is converted from the quarter-wave retardation plate to the linearly polarized light in the direction blocked by the linear polarizing plate, and is then blocked by the subsequent linear polarizing plate, as a result of which, as a result, emission is significantly suppressed.
이 1/4파장위상차판에 관하여, 특허문헌 2에는, 1/2파장판, 1/4파장판을 조합하여 1/4파장위상차판을 구성함으로써, 이 광학필름을 역분산특성에 의해 구성하는 방법이 제안되어 있다. 이 방법의 경우, 컬러화상의 표시에 제공하는 넓은 파장대역에 있어서, 양의 분산특성에 따른 액정재료를 사용하여 역분산특성에 따라 광학필름을 구성할 수 있다.Regarding this 1/4 wavelength retardation plate, in Patent Document 2, a 1/2 wave plate and a 1/4 wave plate are combined to form a 1/4 wave retardation plate, so that this optical film is constructed by inverse dispersion characteristics. A method is proposed. In the case of this method, in a wide wavelength band provided for the display of a color image, an optical film can be constructed according to the inverse dispersion characteristic by using a liquid crystal material according to the positive dispersion characteristic.
또한 최근, 이 위상차층에 적용가능한 액정재료로서, 역분산특성을 구비하는 것이 제안되어 있다(특허문헌 3, 4). 이러한 역분산특성의 액정재료에 따르면, 1/2파장판, 1/4파장판을 조합하여 2층의 위상차층에 의해 1/4파장위상차판을 구성하는 대신, 위상차층을 단층에 의해 구성하여 역분산특성을 확보할 수 있고, 이에 따라 넓은 파장대역에 있어서 원하는 위상차를 확보하는 것이 가능한 광학필름을 간이한 구성에 의해 실현할 수 있다.Furthermore, in recent years, as a liquid crystal material applicable to this retardation layer, the thing provided with the reverse dispersion characteristic is proposed (patent document 3, 4). According to the liquid crystal material of such reverse dispersion characteristics, the phase difference layer is composed of a single layer, instead of forming a quarter-wave retardation plate by two layers of retardation layers by combining a half-wave plate and a quarter-wave plate. An optical film capable of securing the reverse dispersion characteristics and thereby securing a desired retardation in a wide wavelength band can be realized with a simple configuration.
액정을 배향시키기 위해서는 배향층이 이용된다. 배향층의 형성방법으로는, 예를 들어 러빙법이나 광배향법이 알려져 있으며, 광배향법은 러빙법의 문제점인 정전기나 먼지의 발생이 없어, 정량적인 배향처리의 제어가 가능한 점에서 유용하다.An alignment layer is used to orient the liquid crystal. As a method of forming an alignment layer, for example, a rubbing method or a photo-alignment method is known, and the photo-alignment method is useful in that it does not generate static electricity or dust, which is a problem of the rubbing method, and allows quantitative control of the alignment treatment. .
광배향법을 이용한 배향재 형성에서는, 이용가능한 광배향성의 재료로서, 측쇄에 신나모일기 및 칼콘기 등의 광이량화부위를 갖는 아크릴 수지나 폴리이미드 수지 등이 알려져 있다. 이들 수지는, 편광UV조사함으로써, 액정의 배향을 제어하는 성능(이하, 액정배향성이라고도 한다.)을 나타내는 것이 보고되어 있다(특허문헌 5~특허문헌 7을 참조.).In the formation of an orientation material using the photo-alignment method, as a usable photo-alignment material, an acrylic resin or polyimide resin having a photodimerization site such as a cinnamoyl group and a chalcone group in a side chain is known. It has been reported that these resins exhibit the performance (hereinafter, also referred to as liquid crystal orientation) for controlling the orientation of the liquid crystal by polarized UV irradiation (refer to Patent Documents 5 to 7).
또한, 신나모일부위를 이용하는 광배향제에 있어서, 배향감도의 향상 및 용제내성의 부여를 위해 열가교계를 도입한 예도 있다(특허문헌 8 및 9를 참조.).In addition, in a photo-alignment agent using a cinnamoyl moiety, there is an example in which a thermal crosslinking system is introduced to improve orientation sensitivity and impart solvent resistance (see Patent Documents 8 and 9).
한편, 경화막에 열가교계를 도입하는 경우, 특히 가교제와 가교촉매를 공존시킨 상태에서, 경화막 형성 조성물을 안정되게 보존할 수 있다면, 취급성에 있어서 메리트가 크다. 따라서, 이 보존안정성을 개선할 수 있는 간편한 방법이 요구되고 있다. 여기서, 특허문헌 8 등에는, TAC기재를 이용하는 경우는, 알코올용매가 바람직하다는 기재가 있고, 이 이유로서, TAC필름이 내성을 나타낸다는 것이 기재되어 있다. 한편, 그 특허문헌들에는 알코올용매를, 바니시를 안정되게 하기 위해 첨가한다는 것은 기재되어 있지 않고, 또한, TAC필름과 배향재와의 밀착성을 담보하기 위해, 알코올용매와 함께, TAC를 용해하는 지방산에스테르용매를 혼합한다는 것은, 기재되어 있지 않다.On the other hand, when a thermal crosslinking system is introduced into a cured film, particularly in a state in which a crosslinking agent and a crosslinking catalyst are coexisted, if the cured film forming composition can be stably stored, there is a great advantage in handling properties. Therefore, there is a demand for a simple method capable of improving the storage stability. Here, in Patent Document 8 and the like, there is a description that an alcohol solvent is preferable when a TAC substrate is used, and as this reason, it is described that the TAC film exhibits resistance. On the other hand, in those patent documents, it is not described that an alcohol solvent is added to stabilize the varnish, and in order to ensure adhesion between the TAC film and the orientation material, a fatty acid that dissolves TAC together with the alcohol solvent The mixing of the ester solvent is not described.
본 발명은, 이상의 지견이나 검토결과에 기초하여 이루어진 것이다. 즉, 그 목적은, 우수한 배향감도를 가지며, 배향성도 우수하고, TAC필름과의 밀착성도 우수한 배향재를 부여함과 함께, 보존안정성이 향상된 경화막 형성 조성물을 제공하는 것이다.The present invention has been made based on the above knowledge and examination results. That is, the objective is to provide the cured film formation composition which has the outstanding orientation sensitivity, is excellent also in orientation, and is excellent also in adhesiveness with a TAC film, and is improved storage stability while providing the orientation material.
본 발명의 다른 목적 및 이점은, 이하의 기재로부터 분명해질 것이다.Other objects and advantages of the present invention will become apparent from the following description.
본 발명의 제1의 태양은,A first aspect of the present invention is
(A)광배향성기와 하이드록시기, 카르복실기 및 아미노기로부터 선택되는 어느 1개의 치환기를 갖는 화합물,(A) a compound having any one substituent selected from a photo-alignment group, a hydroxyl group, a carboxyl group, and an amino group;
(B)하이드록시기, 카르복실기 및 아미노기로부터 선택되는 1종 또는 2종 이상의 치환기를 갖는 친수성 폴리머,(B) a hydrophilic polymer having one or more substituents selected from a hydroxyl group, a carboxyl group and an amino group;
(C)N-하이드록시메틸 화합물 또는 N-알콕시메틸(메트)아크릴아미드 화합물을 포함하는 모노머를 중합한 폴리머,(C) a polymer obtained by polymerizing a monomer containing an N-hydroxymethyl compound or an N-alkoxymethyl (meth)acrylamide compound;
(D)가교촉매, 그리고,(D) a crosslinking catalyst, and
탄소수 1~5의 알코올과, 탄소수 1~4의 지방산의 탄소수 1~4알킬에스테르와의 쌍방을 포함하는 용제를 함유하는 것을 특징으로 하는 경화막 형성 조성물에 관한 것이다.It is related with the cured film formation composition characterized by containing the solvent containing both C1-C5 alcohol and C1-C4 alkylester of a C1-C4 fatty acid.
본 발명의 제1의 태양에 있어서, (A)성분의 광배향성기가 광이량화 또는 광이성화하는 구조의 관능기인 것이 바람직하다.1st aspect of this invention WHEREIN: It is preferable that the photo-alignment group of (A) component is a functional group of the structure which photodimerizes or photoisomerizes.
본 발명의 제1의 태양에 있어서, (A)성분의 광배향성기가 신나모일기인 것이 바람직하다.1st aspect of this invention WHEREIN: It is preferable that the photo-alignment group of (A) component is a cinnamoyl group.
본 발명의 제1의 태양에 있어서, (A)성분의 광배향성기가 아조벤젠구조의 기인 것이 바람직하다.1st aspect of this invention WHEREIN: It is preferable that the photo-alignment group of (A) component is group of an azobenzene structure.
본 발명의 제1의 태양에 있어서, (B)성분이, 폴리에테르폴리올, 폴리에스테르폴리올, 폴리카보네이트폴리올 및 폴리카프로락톤폴리올로 이루어지는 군으로부터 선택된 적어도 1종의 폴리머인 것이 바람직하다.1st aspect of this invention WHEREIN: It is preferable that (B) component is at least 1 sort(s) of polymer selected from the group which consists of polyether polyol, polyester polyol, polycarbonate polyol, and polycaprolactone polyol.
본 발명의 제1의 태양에 있어서, (B)성분이 셀룰로오스 또는 그의 유도체인 것이 바람직하다.1st aspect of this invention WHEREIN: It is preferable that (B) component is a cellulose or its derivative(s).
본 발명의 제1의 태양에 있어서, (B)성분이, 폴리에틸렌글리콜에스테르기 및 탄소원자수 2 내지 5의 하이드록시알킬에스테르기 중 적어도 일방과, 카르복실기 및 페놀성 하이드록시기 중 적어도 일방을 갖는 아크릴중합체인 것이 바람직하다.1st aspect of this invention WHEREIN: The (B) component has at least one of a polyethyleneglycol ester group and a C2-C5 hydroxyalkyl ester group, and at least one of a carboxyl group and a phenolic hydroxyl group. It is preferably a polymer.
본 발명의 제1의 태양에 있어서, (B)성분이, 폴리에틸렌글리콜에스테르기를 갖는 모노머 및 탄소원자수 2 내지 5의 하이드록시알킬에스테르기를 갖는 모노머 중 적어도 일방과, 카르복실기를 갖는 모노머 및 페놀성 하이드록시기를 갖는 모노머 중 적어도 일방을 포함하는 모노머의 중합반응에 의해 얻어지는 아크릴공중합체인 것이 바람직하다.1st aspect of this invention WHEREIN: (B) component has at least one of the monomer which has a polyethyleneglycol ester group, and the monomer which has a C2-C5 hydroxyalkyl ester group, The monomer which has a carboxyl group, and phenolic hydroxy It is preferable that it is an acrylic copolymer obtained by the polymerization reaction of the monomer containing at least one of the monomers which have a group.
또한, 본 발명의 제1의 태양에 있어서, (B)성분이, 하이드록시알킬기를 측쇄에 갖는 아크릴중합체인 것이 바람직하다.Moreover, in the 1st aspect of this invention, it is preferable that (B) component is an acrylic polymer which has a hydroxyalkyl group in a side chain.
또한, 본 발명의 제1의 태양에 있어서, (E)성분으로서, 밀착향상성분을 추가로 함유하는 것이 바람직하다.Moreover, in the 1st aspect of this invention, as (E) component, it is preferable to contain an adhesion|adherence improving component further.
본 발명의 제1의 태양에 있어서, (A)성분과 (B)성분의 비율이 질량비로 5:95 내지 60:40인 것이 바람직하다.1st aspect of this invention WHEREIN: It is preferable that the ratio of (A) component and (B) component is 5:95-60:40 by mass ratio.
본 발명의 제1의 태양에 있어서, (A)성분의 화합물과 (B)성분의 폴리머의 합계량인 100질량부에 기초하여, 10질량부 내지 150질량부의 (C)성분을 함유하는 것이 바람직하다.1st aspect of this invention WHEREIN: Based on 100 mass parts which is the total amount of the compound of (A) component, and the polymer of (B) component, it is preferable to contain 10 mass parts - 150 mass parts (C)component. .
본 발명의 제1의 태양에 있어서, (A)성분의 화합물과 (B)성분의 폴리머의 합계량인 100질량부에 대해 0.01질량부 내지 10질량부의 (D)성분을 함유하는 것이 바람직하다.1st aspect of this invention WHEREIN: It is preferable to contain 0.01 mass parts - 10 mass parts (D)component with respect to 100 mass parts which is the total amount of the compound of (A) component, and the polymer of (B) component.
본 발명의 제2의 태양은, 본 발명의 제1의 태양의 경화막 형성 조성물을 이용하여 얻어지는 것을 특징으로 하는 배향재에 관한 것이다.A 2nd aspect of this invention is obtained using the cured film formation composition of a 1st aspect of this invention, It relates to the orientation material characterized by the above-mentioned.
본 발명의 제3의 태양은, 본 발명의 제1의 태양의 경화막 형성 조성물로부터 얻어지는 경화막을 사용하여 형성되는 것을 특징으로 하는 위상차재에 관한 것이다.A 3rd aspect of this invention is formed using the cured film obtained from the cured film formation composition of the 1st aspect of this invention, It relates to the retardation material characterized by the above-mentioned.
본 발명의 제1의 태양에 따르면, 우수한 배향감도를 가지며, 배향성도 우수하고, TAC필름과의 밀착성도 우수한 배향재를 부여함과 함께, 보존안정성이 향상된 경화막 형성 조성물을 제공할 수 있다.According to the first aspect of the present invention, it is possible to provide an orientation material having excellent orientation sensitivity, excellent orientation, and excellent adhesion to a TAC film, and a cured film forming composition having improved storage stability.
본 발명의 제2의 태양에 따르면, 우수한 배향감도, 패턴형성성 및 투명성을 가지며, 게다가, 배향균일성도 우수한 배향재를 제공할 수 있다.According to the second aspect of the present invention, it is possible to provide an orientation material having excellent orientation sensitivity, pattern formability and transparency, and also excellent in orientation uniformity.
본 발명의 제3의 태양에 따르면, 알칼리유리 상에서도 높은 효율로 형성할 수 있어 광학패터닝이 가능한 위상차재를 제공할 수 있다.According to the third aspect of the present invention, it is possible to provide a retardation material that can be formed with high efficiency even on alkali glass and can be optically patterned.
<경화막 형성 조성물><Cured film forming composition>
본 실시의 형태의 경화막 형성 조성물은, (A)성분인 저분자의 광배향성분과, (B)성분인 친수성 폴리머와, (C)성분인 N-하이드록시메틸 화합물 또는 N-알콕시메틸(메트)아크릴아미드 화합물을 포함하는 모노머를 중합한 폴리머, 및 (D)성분인 가교촉매를 함유한다. 본 실시의 형태의 경화막 형성 조성물은, (A)성분, (B)성분, (C)성분, (D)에 더하여, 추가로 (E)성분으로서의 경화막의 접착성을 향상시키는 성분도 함유할 수 있다. 그리고, 본 발명의 효과를 손상시키지 않는 한, 기타 첨가제를 함유할 수 있다.The cured film formation composition of this embodiment is the low molecular photo-alignment component which is (A) component, the hydrophilic polymer which is (B) component, and the N-hydroxymethyl compound or N-alkoxymethyl (meth) which is (C)component It contains the polymer which superposed|polymerized the monomer containing an acrylamide compound, and the crosslinking catalyst which is (D)component. In addition to (A) component, (B) component, (C) component, and (D), the cured film formation composition of this embodiment can also contain the component which improves the adhesiveness of the cured film as (E) component further. have. In addition, other additives may be contained as long as the effects of the present invention are not impaired.
이하, 각 성분의 상세를 설명한다.Hereinafter, the detail of each component is demonstrated.
<(A)성분><(A) component>
본 실시의 형태의 경화막 형성 조성물에 함유되는 (A)성분은, 상기 서술한, 저분자의 광배향성분이다.(A) component contained in the cured film formation composition of this embodiment is the above-mentioned low molecular photo-alignment component.
그리고, (A)성분인 저분자의 광배향성분은, 광배향성기와 하이드록시기, 카르복실기 및 아미노기로부터 선택되는 어느 1개의 치환기를 갖는 화합물로 할 수 있다. 광배향성기와 하이드록시기, 카르복실기 및 아미노기로부터 선택되는 어느 1개의 치환기를 갖는 화합물에 있어서는, 상기 서술한 바와 같이, 광반응성기가 광반응성분에 있어서의 소수성의 광반응부를 구성하고, 하이드록시기 등이 친수성의 열반응부를 구성한다.And the low-molecular photo-alignment component which is (A) component can be made into the compound which has any one substituent chosen from a photo-alignment group, a hydroxyl group, a carboxyl group, and an amino group. In the compound having any one substituent selected from a photo-alignment group, a hydroxyl group, a carboxyl group, and an amino group, as described above, the photoreactive group constitutes a hydrophobic photoreactive moiety in the photoreactive component, a hydroxyl group, etc. This hydrophilic thermal reaction part is constituted.
한편, 본 발명에 있어서, 광배향성기로는 광이량화 또는 광이성화하는 구조부위의 관능기를 말한다.On the other hand, in the present invention, the photo-alignment group refers to a functional group of a structural site to be photodimerized or photoisomerized.
광이량화하는 구조부위란, 광조사에 의해 이량체를 형성하는 부위이며, 그 구체예로는 신나모일기, 칼콘기, 쿠마린기, 안트라센기 등을 들 수 있다. 이들 중 가시광영역에서의 높은 투명성 및 광이량화반응성을 갖는 신나모일기가 바람직하다. 또한, 광이성화하는 구조부위란, 광조사에 의해 시스체와 트랜스체로 변하는 구조부위를 가리키며, 그 구체예로는 아조벤젠구조, 스틸벤구조 등으로 이루어지는 부위를 들 수 있다. 이들 중 반응성이 높은 점에서 아조벤젠구조가 바람직하다. 광배향성기와 하이드록시기를 갖는 화합물은, 예를 들어, 하기 식으로 표시된다.The structural site for photodimerization is a site for forming a dimer by light irradiation, and specific examples thereof include a cinnamoyl group, a chalcone group, a coumarin group, an anthracene group, and the like. Among them, a cinnamoyl group having high transparency and photodimerization reactivity in the visible region is preferable. In addition, the structural moiety to be photoisomerized refers to a structural moiety that changes into a cis-form and a trans-form upon irradiation with light, and specific examples thereof include a moiety composed of an azobenzene structure, a stilbene structure, and the like. Among these, the azobenzene structure is preferable at a point with high reactivity. The compound which has a photo-alignment group and a hydroxyl group is represented by a following formula, for example.
[화학식 1][Formula 1]
상기 식 중, A1과 A2는 각각 독립적으로, 수소원자 또는 메틸기를 나타내고, X1은 단결합, 에테르결합, 에스테르결합, 아미드결합, 우레탄결합, 아미노결합 또는 그들의 조합으로부터 선택되는 1종 또는 2종 이상의 결합을 개재하여, 탄소원자수 1 내지 18의 알킬렌, 페닐렌, 비페닐렌 또는 그들의 조합으로부터 선택되는 1 내지 3의 단위가 결합하여 이루어지는 구조를 나타낸다. X2는 수소원자, 할로겐원자, 시아노기, 탄소원자수 1 내지 18의 알킬기, 페닐기, 비페닐기 또는 시클로헥실기를 나타낸다. 그때, 탄소원자수 1 내지 18의 알킬기, 페닐기, 비페닐기 및 시클로헥실기는, 공유결합, 에테르결합, 에스테르결합, 아미드결합 또는 요소결합을 개재하여 결합할 수도 있다. X5는 하이드록시기, 카르복실기, 아미노기 또는 알콕시실릴기를 나타낸다. X는 단결합, 산소원자 또는 황원자를 나타낸다. X6은 하이드록시기, 메르캅토기, 탄소원자수 1 내지 10의 알콕시기, 탄소원자수 1 내지 10의 알킬티오기 또는 페닐기를 나타낸다. X7은 각각 독립적으로 단결합, 탄소원자수 1 내지 20의 알킬렌기, 방향족환기, 또는, 지방족환기를 나타낸다. 여기서 탄소원자수 1 내지 20의 알킬렌기는 분지상이어도 직쇄상이어도 된다.In the above formula, A 1 and A 2 each independently represent a hydrogen atom or a methyl group, and X 1 is one selected from a single bond, an ether bond, an ester bond, an amide bond, a urethane bond, an amino bond, or a combination thereof; A structure formed by bonding 1 to 3 units selected from alkylene having 1 to 18 carbon atoms, phenylene, biphenylene, or a combination thereof via two or more bonds is shown. X 2 represents a hydrogen atom, a halogen atom, a cyano group, an alkyl group having 1 to 18 carbon atoms, a phenyl group, a biphenyl group or a cyclohexyl group. In that case, the alkyl group, phenyl group, biphenyl group and cyclohexyl group having 1 to 18 carbon atoms may be bonded via a covalent bond, an ether bond, an ester bond, an amide bond or a urea bond. X 5 represents a hydroxyl group, a carboxyl group, an amino group, or an alkoxysilyl group. X represents a single bond, an oxygen atom or a sulfur atom. X 6 represents a hydroxy group, a mercapto group, an alkoxy group having 1 to 10 carbon atoms, an alkylthio group having 1 to 10 carbon atoms, or a phenyl group. X 7 each independently represents a single bond, an alkylene group having 1 to 20 carbon atoms, an aromatic ring group, or an aliphatic ring group. Here, the C1-C20 alkylene group may be branched or linear may be sufficient as it.
한편, 이들 치환기에 있어서, 페닐렌, 페닐기, 비페닐렌과 비페닐기는, 탄소원자수 1 내지 4의 알킬기, 탄소원자수 1 내지 4의 알콕시기, 할로겐원자, 트리플루오로메틸기 및 시아노기로부터 선택되는 동일 또는 상이한 1 또는 복수의 치환기에 의해 치환되어 있을 수도 있다.On the other hand, in these substituents, phenylene, phenyl group, biphenylene and biphenyl group are selected from an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a halogen atom, a trifluoromethyl group and a cyano group. It may be substituted by the same or different 1 or several substituents.
상기 식 중, R1, R2, R3, R4, R5, R6, R7 및 R8은, 각각 독립적으로 수소원자, 탄소원자수 1 내지 4의 알킬기, 탄소원자수 1 내지 4의 알콕시기, 할로겐원자, 트리플루오로메틸기 또는 시아노기를 나타낸다.In the above formula, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are each independently a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, or alkoxy having 1 to 4 carbon atoms. group, a halogen atom, a trifluoromethyl group or a cyano group.
(A)성분인 광배향성기와 하이드록시기를 갖는 화합물의 구체예로는, 예를 들어, 4-(8-하이드록시옥틸옥시)계피산메틸에스테르, 4-(6-하이드록시헥실옥시)계피산메틸에스테르, 4-(4-하이드록시부틸옥시)계피산메틸에스테르, 4-(3-하이드록시프로필옥시)계피산메틸에스테르, 4-(2-하이드록시에틸옥시)계피산메틸에스테르, 4-하이드록시메틸옥시계피산메틸에스테르, 4-하이드록시계피산메틸에스테르, 4-(8-하이드록시옥틸옥시)계피산에틸에스테르, 4-(6-하이드록시헥실옥시)계피산에틸에스테르, 4-(4-하이드록시부틸옥시)계피산에틸에스테르, 4-(3-하이드록시프로필옥시)계피산에틸에스테르, 4-(2-하이드록시에틸옥시)계피산에틸에스테르, 4-하이드록시메틸옥시계피산에틸에스테르, 4-하이드록시계피산에틸에스테르, 4-(8-하이드록시옥틸옥시)계피산페닐에스테르, 4-(6-하이드록시헥실옥시)계피산페닐에스테르, 4-(4-하이드록시부틸옥시)계피산페닐에스테르, 4-(3-하이드록시프로필옥시)계피산페닐에스테르, 4-(2-하이드록시에틸옥시)계피산페닐에스테르, 4-하이드록시메틸옥시계피산페닐에스테르, 4-하이드록시계피산페닐에스테르, 4-(8-하이드록시옥틸옥시)계피산비페닐에스테르, 4-(6-하이드록시헥실옥시)계피산비페닐에스테르, 4-(4-하이드록시부틸옥시)계피산비페닐에스테르, 4-(3-하이드록시프로필옥시)계피산비페닐에스테르, 4-(2-하이드록시에틸옥시)계피산비페닐에스테르, 4-하이드록시메틸옥시계피산비페닐에스테르, 4-하이드록시계피산비페닐에스테르, 계피산8-하이드록시옥틸에스테르, 계피산6-하이드록시헥실에스테르, 계피산4-하이드록시부틸에스테르, 계피산3-하이드록시프로필에스테르, 계피산2-하이드록시에틸에스테르, 계피산하이드록시메틸에스테르, 4-(8-하이드록시옥틸옥시)아조벤젠, 4-(6-하이드록시헥실옥시)아조벤젠, 4-(4-하이드록시부틸옥시)아조벤젠, 4-(3-하이드록시프로필옥시)아조벤젠, 4-(2-하이드록시에틸옥시)아조벤젠, 4-하이드록시메틸옥시아조벤젠, 4-하이드록시아조벤젠, 4-(8-하이드록시옥틸옥시)칼콘, 4-(6-하이드록시헥실옥시)칼콘, 4-(4-하이드록시부틸옥시)칼콘, 4-(3-하이드록시프로필옥시)칼콘, 4-(2-하이드록시에틸옥시)칼콘, 4-하이드록시메틸옥시칼콘, 4-하이드록시칼콘, 4’-(8-하이드록시옥틸옥시)칼콘, 4’-(6-하이드록시헥실옥시)칼콘, 4’-(4-하이드록시부틸옥시)칼콘, 4’-(3-하이드록시프로필옥시)칼콘, 4’-(2-하이드록시에틸옥시)칼콘, 4’-하이드록시메틸옥시칼콘, 4’-하이드록시칼콘, 7-(8-하이드록시옥틸옥시)쿠마린, 7-(6-하이드록시헥실옥시)쿠마린, 7-(4-하이드록시부틸옥시)쿠마린, 7-(3-하이드록시프로필옥시)쿠마린, 7-(2-하이드록시에틸옥시)쿠마린, 7-하이드록시메틸옥시쿠마린, 7-하이드록시쿠마린, 6-하이드록시옥틸옥시쿠마린, 6-하이드록시헥실옥시쿠마린, 6-(4-하이드록시부틸옥시)쿠마린, 6-(3-하이드록시프로필옥시)쿠마린, 6-(2-하이드록시에틸옥시)쿠마린, 6-하이드록시메틸옥시쿠마린, 6-하이드록시쿠마린을 들 수 있다.(A) As a specific example of the compound which has the photo-alignment group which is a component and a hydroxyl group, For example, 4-(8-hydroxyoctyloxy) cinnamic acid methyl ester, 4-(6-hydroxyhexyloxy) methyl cinnamate Ester, 4-(4-hydroxybutyloxy) cinnamic acid methyl ester, 4-(3-hydroxypropyloxy) cinnamic acid methyl ester, 4-(2-hydroxyethyloxy) cinnamic acid methyl ester, 4-hydroxymethyloxy Cinnamon methyl ester, 4-hydroxycinnamic acid methyl ester, 4-(8-hydroxyoctyloxy) cinnamic acid ethyl ester, 4-(6-hydroxyhexyloxy) cinnamic acid ethyl ester, 4-(4-hydroxybutyloxy) ) Cinnamon ethyl ester, 4-(3-hydroxypropyloxy) cinnamic acid ethyl ester, 4-(2-hydroxyethyloxy) cinnamic acid ethyl ester, 4-hydroxymethyloxy cinnamic acid ethyl ester, 4-hydroxycinnamic acid ethyl ester , 4- (8-hydroxyoctyloxy) cinnamic acid phenyl ester, 4- (6-hydroxyhexyloxy) cinnamic acid phenyl ester, 4- (4-hydroxybutyloxy) cinnamic acid phenyl ester, 4- (3-hydroxy) Roxypropyloxy) cinnamic acid phenyl ester, 4-(2-hydroxyethyloxy) cinnamic acid phenyl ester, 4-hydroxymethyloxy cinnamic acid phenyl ester, 4-hydroxycinnamic acid phenyl ester, 4-(8-hydroxyoctyloxy) Cinnamon acid biphenyl ester, 4-(6-hydroxyhexyloxy) cinnamic acid biphenyl ester, 4-(4-hydroxybutyloxy) cinnamic acid biphenyl ester, 4-(3-hydroxypropyloxy) cinnamic acid biphenyl ester , 4-(2-hydroxyethyloxy)cinnamic acid biphenyl ester, 4-hydroxymethyloxycinnamic acid biphenyl ester, 4-hydroxycinnamic acid biphenyl ester, cinnamic acid 8-hydroxyoctyl ester, cinnamic acid 6-hydroxyhexyl Ester, cinnamic acid 4-hydroxybutyl ester, cinnamic acid 3-hydroxypropyl ester, cinnamic acid 2-hydroxyethyl ester, cinnamic acid hydroxymethyl ester, 4-(8-hydroxyoctyloxy) azobenzene, 4-(6-hydro hydroxyhexyloxy) azobenzene, 4-(4-hydroxybutyloxy) azobenzene, 4-(3-hydroxypropyloxy) azobenzene, 4-(2-hydroxyethyloxy) azobenzene, 4-hydroxymethyloxyazobenzene , 4-hydroxyazobenzene, 4- (8-hydroxyoctyloxy) chalcone, 4- ( 6-hydroxyhexyloxy) chalcone, 4-(4-hydroxybutyloxy) chalcone, 4-(3-hydroxypropyloxy) chalcone, 4-(2-hydroxyethyloxy) chalcone, 4-hydroxy Methyloxychalcone, 4-hydroxychalcone, 4'-(8-hydroxyoctyloxy)chalcone, 4'-(6-hydroxyhexyloxy)chalcone, 4'-(4-hydroxybutyloxy)chalcone, 4'-(3-hydroxypropyloxy)chalcone, 4'-(2-hydroxyethyloxy)chalcone, 4'-hydroxymethyloxychalcone, 4'-hydroxychalcone, 7-(8-hydroxyoctyl) Oxy)coumarin, 7-(6-hydroxyhexyloxy)coumarin, 7-(4-hydroxybutyloxy)coumarin, 7-(3-hydroxypropyloxy)coumarin, 7-(2-hydroxyethyloxy) ) Coumarin, 7-hydroxymethyloxycoumarin, 7-hydroxycoumarin, 6-hydroxyoctyloxycoumarin, 6-hydroxyhexyloxycoumarin, 6-(4-hydroxybutyloxy)coumarin, 6-(3- Hydroxypropyloxy) coumarin, 6-(2-hydroxyethyloxy) coumarin, 6-hydroxymethyloxy coumarin, and 6-hydroxycoumarin are mentioned.
광배향성기와 카르복실기를 갖는 화합물의 구체예로는 계피산, 페룰산, 4-니트로계피산, 4-메톡시계피산, 3,4-디메톡시계피산, 쿠마린-3-카르본산, 4-(N,N-디메틸아미노)계피산 등을 들 수 있다.Specific examples of the compound having a photo-alignment group and a carboxyl group include cinnamic acid, ferulic acid, 4-nitrocinnamic acid, 4-methoxycinnamic acid, 3,4-dimethoxycinnamic acid, coumarin-3-carboxylic acid, 4-(N,N- dimethylamino) cinnamic acid and the like.
광배향성기와 아미노기를 갖는 화합물의 구체예로는 메틸-4-아미노계피산, 에틸-4-아미노계피산, 메틸-3-아미노계피산, 에틸-3-아미노계피산 등을 들 수 있다.Specific examples of the compound having a photo-alignment group and an amino group include methyl-4-aminocinnamic acid, ethyl-4-aminocinnamic acid, methyl-3-aminocinnamic acid, and ethyl-3-aminocinnamic acid.
(A)성분인 저분자의 광배향성분은, 이상의 구체예를 들 수 있는데, 이것들로 한정되는 것은 아니다.(A) Although the above specific example is given as for the low molecular photo-alignment component which is a component, it is not limited to these.
또한, (A)성분인 광배향성분이, 광배향성기와 하이드록시기를 갖는 화합물인 경우, (A)성분으로서, 분자 내에, 광배향성기를 2개 이상 및/또는 하이드록시기를 2개 이상 갖는 화합물을 이용하는 것이 가능하다. 구체적으로는, (A)성분으로서, 분자 내에 1개의 하이드록시기와 함께 2개 이상의 광배향성기를 갖는 화합물이나, 분자 내에 1개의 광배향성기와 함께 2개 이상의 하이드록시기를 갖는 화합물이나, 분자 내에 광배향성기와 하이드록시기를 각각 2개 이상 갖는 화합물을 이용하는 것이 가능하다. 예를 들어, 분자 내에 광배향성기와 하이드록시기를 각각 2개 이상 갖는 화합물에 대해서는, 그 일례로서, 하기 식으로 표시되는 화합물을 나타낼 수 있다.In addition, when the photo-alignment component as component (A) is a compound having a photo-alignment group and a hydroxyl group, as the component (A), a compound having two or more photo-alignment groups and/or two or more hydroxyl groups in the molecule is used. it is possible Specifically, as component (A), a compound having two or more photo-alignment groups together with one hydroxyl group in a molecule, a compound having two or more hydroxyl groups together with one photo-alignment group in a molecule, and photo-alignment property in a molecule It is possible to use compounds each having two or more groups and hydroxyl groups. For example, about the compound which has each two or more of photo-alignment group and a hydroxyl group in a molecule|numerator, the compound represented by the following formula can be shown as the example.
[화학식 2][Formula 2]
이러한 화합물을 적당히 선택함으로써, (A)성분인 광배향성분의 분자량을 높이는 제어가 가능해진다. 그 결과, 후술하는 바와 같이, (A)성분인 광배향성분 및 (B)성분인 폴리머와 (C)성분인 가교제가 열반응할 때에, (A)성분인 광배향성분이 승화되는 것을 억제할 수 있다. 그리고, 본 실시의 형태의 경화막 형성 조성물은, 경화막으로서, 광반응효율이 높은 배향재를 형성할 수 있다.By selecting such a compound suitably, control which raises the molecular weight of the photo-alignment component which is (A) component becomes possible. As a result, as described later, when the photo-alignment component as component (A) and the polymer as component (B) and the cross-linking agent as component (C) thermally react, the sublimation of the photo-alignment component as component (A) can be suppressed. have. And the cured film formation composition of this embodiment can form the orientation material with high photoreaction efficiency as a cured film.
또한, 본 실시의 형태의 경화막 형성 조성물에 있어서의 (A)성분의 화합물로는, 광배향성기와 하이드록시기, 카르복실기 및 아미노기로부터 선택되는 어느 1개의 치환기를 갖는, 복수종의 화합물의 혼합물일 수도 있다.Moreover, as a compound of (A) component in the cured film formation composition of this embodiment, it has a photo-alignment group, a hydroxyl group, a carboxyl group, and any one substituent selected from an amino group, It is a mixture of multiple types of compounds may be
<(B)성분><(B) component>
본 실시의 형태의 경화막 형성 조성물에 함유되는 (B)성분은, 친수성의 폴리머이다.(B) component contained in the cured film formation composition of this embodiment is a hydrophilic polymer.
그리고, (B)성분인 폴리머는, 하이드록시기, 카르복실기 및 아미노기로부터 선택되는 1종 또는 2종 이상의 치환기를 갖는 폴리머(이하, 특정중합체라고도 한다.)로 할 수 있다.And the polymer which is (B) component can be set as the polymer (henceforth a specific polymer) which has 1 type(s) or 2 or more types of substituents chosen from a hydroxyl group, a carboxyl group, and an amino group.
본 실시의 형태의 경화막 형성 조성물에 있어서, (B)성분인 특정중합체로는, (A)성분보다 친수성이도록, 높은 친수성을 갖춘 고친수성 폴리머의 선택이 바람직하다. 그리고, 특정중합체는, 하이드록시기나 카르복실기나 아미노기 등의 친수성기를 갖는 폴리머인 것이 바람직하고, 구체적으로는, 하이드록시기, 카르복실기 및 아미노기로부터 선택되는 1종 또는 2종 이상의 치환기를 갖는 폴리머인 것이 바람직하다.Cured film formation composition of this embodiment WHEREIN: As a specific polymer which is (B) component, selection of the high hydrophilic polymer with high hydrophilicity is preferable so that it may become more hydrophilic than (A) component. The specific polymer is preferably a polymer having a hydrophilic group such as a hydroxyl group, a carboxyl group, or an amino group, and specifically, a polymer having one or two or more substituents selected from a hydroxyl group, a carboxyl group, and an amino group. do.
(B)성분인 폴리머로는, 예를 들어, 아크릴중합체, 폴리아믹산, 폴리이미드, 폴리비닐알코올, 폴리에스테르, 폴리에스테르폴리카르본산, 폴리에테르폴리올, 폴리에스테르폴리올, 폴리카보네이트폴리올, 폴리카프로락톤폴리올, 폴리알킬렌이민, 폴리알릴아민, 셀룰로오스류(셀룰로오스 또는 그의 유도체), 페놀노볼락 수지, 멜라민포름알데히드 수지 등의 직쇄구조 또는 분지구조를 갖는 폴리머, 시클로덱스트린류 등의 환상 폴리머 등을 들 수 있다.(B) As a polymer which is a component, For example, acrylic polymer, polyamic acid, polyimide, polyvinyl alcohol, polyester, polyester polycarboxylic acid, polyether polyol, polyester polyol, polycarbonate polyol, polycaprolactone Polyols, polyalkyleneimines, polyallylamines, celluloses (cellulose or derivatives thereof), phenol novolac resins, polymers having a linear or branched structure such as melamine-formaldehyde resins, cyclic polymers such as cyclodextrins, etc. can
이 중, 아크릴중합체로는 아크릴산에스테르, 메타크릴산에스테르, 스티렌 등의 불포화이중결합을 갖는 모노머를 중합하여 얻어지는 중합체가 적용될 수 있다.Among them, as the acrylic polymer, a polymer obtained by polymerizing a monomer having an unsaturated double bond such as acrylic acid ester, methacrylic acid ester, or styrene may be applied.
(B)성분인 특정중합체로는, 바람직하게는, 하이드록시알킬시클로덱스트린류, 셀룰로오스류, 폴리에틸렌글리콜에스테르기 및 탄소원자수 2 내지 5의 하이드록시알킬에스테르기 중 적어도 일방과, 카르복실기 및 페놀성 하이드록시기 중 적어도 일방을 갖는 아크릴중합체, 아미노알킬기를 측쇄에 갖는 아크릴중합체, 폴리하이드록시에틸메타크릴레이트 등의 하이드록시알킬기를 측쇄에 갖는 아크릴중합체, 폴리에테르폴리올, 폴리에스테르폴리올, 폴리카보네이트폴리올 및 폴리카프로락톤폴리올이다.(B) As a specific polymer which is a component, Preferably, at least one of hydroxyalkylcyclodextrins, celluloses, a polyethyleneglycol ester group, and a C2-C5 hydroxyalkyl ester group, a carboxyl group, and a phenolic hydroxy Acrylic polymers having at least one of hydroxy groups, acrylic polymers having an aminoalkyl group in a side chain, acrylic polymers having a hydroxyalkyl group in a side chain such as polyhydroxyethyl methacrylate, polyether polyols, polyester polyols, polycarbonate polyols and It is polycaprolactone polyol.
(B)성분의 특정중합체의 바람직한 일례인, 폴리에틸렌글리콜에스테르기 및 탄소원자수 2 내지 5의 하이드록시알킬에스테르기 중 적어도 일방과, 카르복실기 및 페놀성 하이드록시기 중 적어도 일방을 갖는 아크릴중합체는, 이러한 구조를 갖는 아크릴중합체이면 되고, 아크릴중합체를 구성하는 고분자의 주쇄의 골격 및 측쇄의 종류 등에 대하여 특별히 한정되지 않는다.(B) An acrylic polymer having at least one of a polyethylene glycol ester group and a hydroxyalkyl ester group having 2 to 5 carbon atoms, and at least one of a carboxyl group and a phenolic hydroxyl group, which is a preferable example of the specific polymer of the component, As long as it is an acrylic polymer having a structure, it is not particularly limited with respect to the backbone of the main chain of the polymer constituting the acrylic polymer and the kind of side chains.
폴리에틸렌글리콜에스테르기 및 탄소원자수 2 내지 5의 하이드록시알킬에스테르기 중 적어도 일방을 갖는 구조단위로서, 바람직한 구조단위는 하기 식[B1]로 표시된다.As the structural unit having at least one of a polyethylene glycol ester group and a hydroxyalkyl ester group having 2 to 5 carbon atoms, a preferable structural unit is represented by the following formula [B1].
카르복실기 및 페놀성 하이드록시기 중 적어도 일방을 갖는 구조단위로서, 바람직한 구조단위는 하기 식[B2]로 표시된다.As the structural unit having at least one of a carboxyl group and a phenolic hydroxyl group, a preferable structural unit is represented by the following formula [B2].
[화학식 3][Formula 3]
상기 식[B1] 및 식[B2] 중, X3 및 X4는 각각 독립적으로 수소원자 또는 메틸기를 나타내고, Y1은 H-(OCH2CH2)n-기(여기서, n의 값은 2 내지 50이고, 바람직하게는 2 내지 10이다.) 또는 탄소원자수 2 내지 5의 하이드록시알킬기를 나타내고, Y2는 카르복실기 또는 페놀성 하이드록시기를 나타낸다.In Formulas [B1] and [B2], X 3 and X 4 each independently represents a hydrogen atom or a methyl group, Y 1 is H-(OCH 2 CH 2 ) n -group, where the value of n is 2 to 50, preferably 2 to 10) or a hydroxyalkyl group having 2 to 5 carbon atoms, and Y 2 represents a carboxyl group or a phenolic hydroxyl group.
(B)성분의 예인 아크릴중합체는, 중량평균분자량이 3,000 내지 200,000인 것이 바람직하고, 4,000 내지 150,000인 것이 보다 바람직하고, 5,000 내지 100,000인 것이 더욱 바람직하다. 중량평균분자량이 200,000을 초과하여 과대한 것이면, 용제에 대한 용해성이 저하되어 핸들링성이 저하되는 경우가 있고, 중량평균분자량이 3,000 미만으로 과소한 것이면, 열경화시에 경화부족이 되어 용제내성 및 내열성이 저하되는 경우가 있다. 한편, 중량평균분자량은, 겔퍼미에이션크로마토그래피(GPC)에 의해, 표준자료로서 폴리스티렌을 이용하여 얻어지는 값이다. 이하, 본 명세서에 있어서도 동일하게 한다.(B) It is preferable that weight average molecular weights are 3,000-200,000, as for the acrylic polymer which is an example of a component, it is more preferable that it is 4,000-150,000, It is more preferable that it is 5,000-100,000. If the weight average molecular weight exceeds 200,000, the solubility in solvents may decrease and handleability may decrease. Heat resistance may fall. Meanwhile, the weight average molecular weight is a value obtained using polystyrene as standard data by gel permeation chromatography (GPC). Hereinafter, it is set similarly also in this specification.
(B)성분의 예인 아크릴중합체의 합성방법으로는, 폴리에틸렌글리콜에스테르기 및 탄소원자수 2 내지 5의 하이드록시알킬에스테르기 중 적어도 일방을 갖는 모노머(이하, b1모노머라고도 한다.)와, 카르복실기 및 페놀성 하이드록시기 중 적어도 일방을 갖는 모노머(이하, b2모노머라고도 한다.)를 공중합하는 방법이 간편하다.(B) As a method for synthesizing an acrylic polymer as an example of component, a monomer having at least one of a polyethylene glycol ester group and a hydroxyalkyl ester group having 2 to 5 carbon atoms (hereinafter also referred to as a b1 monomer), a carboxyl group and a phenol A method of copolymerizing a monomer having at least one of the sex hydroxyl groups (hereinafter also referred to as b2 monomer) is simple.
상기 서술한 폴리에틸렌글리콜에스테르기를 갖는 모노머로는, H-(OCH2CH2)n-OH의 모노아크릴레이트 또는 모노메타크릴레이트를 들 수 있다. n의 값은 2 내지 50이고, 바람직하게는 2 내지 10이다.As a monomer which has the above-mentioned polyethyleneglycol ester group, the monoacrylate or monomethacrylate of H-(OCH2CH2) n - OH is mentioned. The value of n is 2 to 50, preferably 2 to 10.
상기 서술한 탄소원자수 2 내지 5의 하이드록시알킬에스테르기를 갖는 모노머로는, 예를 들어, 2-하이드록시에틸메타크릴레이트, 2-하이드록시에틸아크릴레이트, 2-하이드록시프로필메타크릴레이트, 2-하이드록시프로필아크릴레이트, 4-하이드록시부틸아크릴레이트, 4-하이드록시부틸메타크릴레이트를 들 수 있다.As a monomer which has the above-mentioned C2-C5 hydroxyalkyl ester group, 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate, 2-hydroxypropyl methacrylate, 2 -Hydroxypropyl acrylate, 4-hydroxybutyl acrylate, and 4-hydroxybutyl methacrylate are mentioned.
상기 서술한 카르복실기를 갖는 모노머로는, 예를 들어, 아크릴산, 메타크릴산, 비닐안식향산을 들 수 있다.As a monomer which has the above-mentioned carboxyl group, acrylic acid, methacrylic acid, and vinylbenzoic acid are mentioned, for example.
상기 서술한 페놀성 하이드록시기를 갖는 모노머로는, 예를 들어, p-하이드록시스티렌, m-하이드록시스티렌, o-하이드록시스티렌을 들 수 있다.As a monomer which has the above-mentioned phenolic hydroxyl group, p-hydroxystyrene, m-hydroxystyrene, and o-hydroxystyrene are mentioned, for example.
또한, 본 실시의 형태에 있어서는, (B)성분의 예인 아크릴중합체를 합성할 때에, 본 발명의 효과를 손상시키지 않는 한, b1모노머 및 b2모노머 이외의 모노머, 구체적으로는, 하이드록시기 및 카르복실기를 모두 갖지 않는 모노머를 병용할 수 있다.In addition, in this embodiment, when synthesize|combining the acrylic polymer which is an example of (B) component, unless the effect of this invention is impaired, monomers other than b1 monomer and b2 monomer, specifically, a hydroxyl group and a carboxyl group A monomer which does not have all of them can be used together.
그러한 모노머로는, 예를 들어, 메틸아크릴레이트, 에틸아크릴레이트, 프로필아크릴레이트, 이소프로필아크릴레이트, 부틸메타크릴레이트, 부틸아크릴레이트, 이소부틸아크릴레이트, t-부틸아크릴레이트 등의 아크릴산에스테르 화합물, 메틸메타크릴레이트, 에틸메타크릴레이트, 프로필메타크릴레이트, 이소프로필메타크릴레이트, 이소부틸메타크릴레이트, t-부틸메타크릴레이트 등의 메타크릴산에스테르 화합물, 말레이미드, N-메틸말레이미드, N-페닐말레이미드, 및 N-시클로헥실말레이미드 등의 말레이미드 화합물, 아크릴아미드 화합물, 아크릴로니트릴, 말레산무수물, 스티렌 화합물 및 비닐 화합물 등을 들 수 있다.Examples of such monomers include acrylic acid ester compounds such as methyl acrylate, ethyl acrylate, propyl acrylate, isopropyl acrylate, butyl methacrylate, butyl acrylate, isobutyl acrylate, and t-butyl acrylate. , methyl methacrylate, ethyl methacrylate, propyl methacrylate, isopropyl methacrylate, isobutyl methacrylate, methacrylic acid ester compounds such as t-butyl methacrylate, maleimide, N-methyl maleimide , N-phenylmaleimide, and maleimide compounds such as N-cyclohexylmaleimide, acrylamide compounds, acrylonitrile, maleic anhydride, styrene compounds and vinyl compounds.
(B)성분의 예인 아크릴중합체를 얻기 위해 이용하는 b1모노머 및 b2모노머의 사용량은, (B)성분인 아크릴중합체를 얻기 위해 이용하는 전체모노머의 합계량에 기초하여, b1모노머가 2몰% 내지 95몰%, b2모노머가 5몰% 내지 98몰%인 것이 바람직하다.The amount of the b1 monomer and b2 monomer used to obtain the acrylic polymer serving as an example of the component (B) is 2 mol% to 95 mol% of the b1 monomer based on the total amount of all monomers used to obtain the acrylic polymer serving as the component (B). , b2 It is preferable that the monomer is 5 mol% to 98 mol%.
b2모노머로서 카르복실기만을 갖는 모노머를 이용하는 경우, (B)성분인 아크릴중합체를 얻기 위해 이용하는 전체모노머의 합계량에 기초하여, b1모노머가 60몰% 내지 95몰%, b2모노머가 5몰% 내지 40몰%인 것이 바람직하다.When a monomer having only a carboxyl group is used as the b2 monomer, based on the total amount of all monomers used to obtain the acrylic polymer as component (B), the b1 monomer is 60 mol% to 95 mol%, and the b2 monomer is 5 mol% to 40 mol%. % is preferred.
한편, b2모노머로서 페놀성 하이드록시기만을 갖는 모노머를 이용하는 경우, b1모노머가 2몰% 내지 80몰%, b2모노머가 20몰% 내지 98몰%인 것이 바람직하다. b2모노머가 과소한 경우는 액정배향성이 불충분해지기 쉽고, 과대한 경우는 (A)성분과의 상용성이 저하되기 쉽다.On the other hand, when a monomer having only a phenolic hydroxyl group is used as the b2 monomer, it is preferable that the content of the b1 monomer is 2 mol% to 80 mol% and the content of the b2 monomer is 20 mol% to 98 mol%. When there is too little b2 monomer, liquid-crystal orientation tends to become inadequate, and when excessive, compatibility with (A) component falls easily.
(B)성분의 예인 아크릴중합체를 얻는 방법은 특별히 한정되지 않으나, 예를 들어, b1모노머와 b2모노머와 필요에 따라 b1모노머 및 b2모노머 이외의 모노머와 중합개시제 등을 공존시킨 용제 중에 있어서, 50℃ 내지 110℃의 온도하에서 중합반응에 의해 얻어진다. 그때, 이용되는 용제는, b1모노머와 b2모노머, 필요에 따라 이용되는 b1모노머 및 b2모노머 이외의 모노머 및 중합개시제 등을 용해하는 것이면 특별히 한정되지 않는다. 구체예로는, 후술하는 <용제>의 항에 기재한다.The method for obtaining the acrylic polymer as an example of component (B) is not particularly limited, but for example, in a solvent in which the b1 monomer, the b2 monomer, and a monomer other than the b1 monomer and b2 monomer, and a polymerization initiator, etc. coexist in a solvent, 50 It is obtained by polymerization under a temperature of ℃ to 110 ℃. In that case, the solvent used will not be specifically limited if it dissolves monomers other than the b1 monomer and b2 monomer, and the b1 monomer and b2 monomer used as needed, a polymerization initiator, etc. in that case. As a specific example, it describes in the term of the <solvent> mentioned later.
(B)성분의 특정중합체의 바람직한 일례인 아미노알킬기를 측쇄에 갖는 아크릴중합체는, 예를 들어, 아미노에틸아크릴레이트, 아미노에틸메타크릴레이트, 아미노프로필아크릴레이트 및 아미노프로필메타크릴레이트 등의 아미노알킬에스테르모노머를 중합한 것, 또는, 해당 아미노알킬에스테르모노머와, 상기 b1모노머, 상기 b2모노머, 및, 이들 모노머 이외의 모노머, 예를 들어 하이드록시기 및 카르복시기를 모두 갖지 않는 모노머로 이루어지는 군으로부터 선택되는 1종 또는 2종 이상의 모노머를 공중합한 것을 들 수 있다.(B) The acrylic polymer which has an aminoalkyl group in a side chain which is a preferable example of the specific polymer of component, For example, aminoalkyl, such as aminoethyl acrylate, aminoethyl methacrylate, aminopropyl acrylate, and aminopropyl methacrylate Selected from the group consisting of polymerized ester monomers, or the aminoalkyl ester monomer, the b1 monomer, the b2 monomer, and a monomer other than these monomers, for example, a monomer having neither a hydroxyl group nor a carboxyl group. What copolymerized the 1 type, or 2 or more types of monomers used is mentioned.
(B)성분의 특정중합체의 바람직한 일례인 하이드록시알킬기를 측쇄에 갖는 아크릴중합체로는, 예를 들어, 하이드록시에틸아크릴레이트, 하이드록시에틸메타크릴레이트, 하이드록시프로필아크릴레이트, 하이드록시프로필메타크릴레이트, 하이드록시부틸아크릴레이트, 하이드록시부틸메타크릴레이트, 하이드록시펜틸아크릴레이트 및 하이드록시펜틸메타크릴레이트 등의 하이드록시알킬에스테르모노머를 중합한 것, 또는, 해당 하이드록시알킬에스테르모노머와, 상기 b1모노머, 상기 b2모노머, 및, 이들 모노머 이외의 모노머, 예를 들어 하이드록시기 및 카르복시기를 모두 갖지 않는 모노머로 이루어지는 군으로부터 선택되는 1종 또는 2종 이상의 모노머를 공중합한 것을 들 수 있다.(B) As an acrylic polymer which has a hydroxyalkyl group in a side chain which is a preferable example of the specific polymer of component, for example, hydroxyethyl acrylate, hydroxyethyl methacrylate, hydroxypropyl acrylate, hydroxypropyl meth A product obtained by polymerizing hydroxyalkyl ester monomers such as acrylate, hydroxybutyl acrylate, hydroxybutyl methacrylate, hydroxypentyl acrylate and hydroxypentyl methacrylate, or the hydroxyalkyl ester monomer; The above-mentioned b1 monomer, the above-mentioned b2 monomer, and monomers other than these monomers, for example, one or two or more types of monomers selected from the group consisting of monomers having neither a hydroxy group nor a carboxy group are copolymerized.
상기 방법에 의해 얻어지는 (B)성분의 예인 아크릴중합체는, 통상, 용제에 용해된 용액의 상태이다.The acrylic polymer which is an example of (B) component obtained by the said method is the state of the solution melt|dissolved in the solvent normally.
또한, 상기 방법으로 얻어진 (B)성분의 예인 아크릴중합체의 용액을, 교반하의 디에틸에테르나 물 등에 투입하여 재침전시키고, 생성된 침전물을 여과·세정한 후에, 상압 또는 감압하에서, 상온건조 또는 가열건조하여, (B)성분의 예인 아크릴중합체의 분체로 할 수 있다. 상기 조작에 의해, (B)성분의 예인 아크릴중합체와 공존하는 중합개시제 및 미반응의 모노머를 제거할 수 있고, 그 결과, 정제한 (B)성분의 예인 아크릴중합체의 분체가 얻어진다. 한번의 조작으로 충분히 정제할 수 없는 경우는, 얻어진 분체를 용제에 재용해시키고, 상기의 조작을 반복 행하면 된다.In addition, the solution of the acrylic polymer, which is an example of component (B) obtained by the above method, is added to diethyl ether or water under stirring to reprecipitate, and the resulting precipitate is filtered and washed, then dried at room temperature under normal pressure or reduced pressure, or It can be heat-dried and it can be set as the powder of the acrylic polymer which is an example of (B) component. By the said operation, the polymerization initiator and unreacted monomer which coexist with the acrylic polymer which are an example of (B) component can be removed, As a result, the powder of the acrylic polymer which is an example of the refined (B) component is obtained. What is necessary is just to make the obtained powder re-dissolve in a solvent again, and just to perform said operation repeatedly, when refinement|purification cannot fully be carried out by one operation.
(B)성분의 특정중합체의 바람직한 일례인 폴리에테르폴리올로는 폴리에틸렌글리콜, 폴리프로필렌글리콜 및 프로필렌글리콜을 들 수 있고, 또한, 비스페놀A, 트리에틸렌글리콜, 솔비톨 등의 다가알코올에 프로필렌옥사이드나 폴리에틸렌글리콜, 폴리프로필렌글리콜 등을 부가 또는 축합한 것을 들 수 있다. 폴리에테르폴리올의 구체예로는 ADEKA제 아데카폴리에테르 P시리즈, G시리즈, EDP시리즈, BPX시리즈, FC시리즈, CM시리즈, 니찌유제 유니옥스(등록상표) HC-40, HC-60, ST-30E, ST-40E, G-450, G-750, 유니올(등록상표) TG-330, TG-1000, TG-3000, TG-4000, HS-1600D, DA-400, DA-700, DB-400, 노니온(등록상표) LT-221, ST-221, OT-221 등을 들 수 있다.(B) Polyether polyol which is a preferable example of the specific polymer of component includes polyethylene glycol, polypropylene glycol and propylene glycol, Furthermore, polyhydric alcohol, such as bisphenol A, triethylene glycol, sorbitol, propylene oxide and polyethylene glycol , polypropylene glycol, etc. may be added or condensed. Specific examples of the polyether polyol include ADEKA Adeka polyether P series, G series, EDP series, BPX series, FC series, CM series, Nichiyu Uniox (registered trademark) HC-40, HC-60, ST- 30E, ST-40E, G-450, G-750, Uniol (registered trademark) TG-330, TG-1000, TG-3000, TG-4000, HS-1600D, DA-400, DA-700, DB- 400, Nonion (trademark) LT-221, ST-221, OT-221, etc. are mentioned.
(B)성분의 특정중합체의 바람직한 일례인 폴리에스테르폴리올로는, 아디프산, 세바스산, 이소프탈산 등의 다가카르본산에 에틸렌글리콜, 프로필렌글리콜, 부틸렌글리콜, 폴리에틸렌글리콜, 폴리프로필렌글리콜 등의 디올을 반응시킨 것을 들 수 있다. 폴리에스테르폴리올의 구체예로는 DIC제 폴리라이트(등록상표) OD-X-286, OD-X-102, OD-X-355, OD-X-2330, OD-X-240, OD-X-668, OD-X-2108, OD-X-2376, OD-X-2044, OD-X-688, OD-X-2068, OD-X-2547, OD-X-2420, OD-X-2523, OD-X-2555, OD-X-2560, 쿠라레이제 폴리올 P-510, P-1010, P-2010, P-3010, P-4010, P-5010, P-6010, F-510, F-1010, F-2010, F-3010, P-1011, P-2011, P-2013, P-2030, N-2010, PNNA-2016 등을 들 수 있다.(B) As a polyester polyol which is a preferable example of the specific polymer of a component, polyhydric carboxylic acids, such as adipic acid, sebacic acid, isophthalic acid, ethylene glycol, propylene glycol, butylene glycol, polyethylene glycol, polypropylene glycol, etc. What made diol react is mentioned. Specific examples of the polyester polyol include DIC polylite (registered trademark) OD-X-286, OD-X-102, OD-X-355, OD-X-2330, OD-X-240, OD-X- 668, OD-X-2108, OD-X-2376, OD-X-2044, OD-X-688, OD-X-2068, OD-X-2547, OD-X-2420, OD-X-2523, OD-X-2555, OD-X-2560, Kurarayje Polyol P-510, P-1010, P-2010, P-3010, P-4010, P-5010, P-6010, F-510, F- 1010, F-2010, F-3010, P-1011, P-2011, P-2013, P-2030, N-2010, PNNA-2016, etc. are mentioned.
(B)성분의 특정중합체의 바람직한 일례인 폴리카프로락톤폴리올로는, 트리메틸올프로판이나 에틸렌글리콜 등의 다가알코올을 개시제로 하여 ε-카프로락탐을 개환중합시킨 것을 들 수 있다. 폴리카프로락톤폴리올의 구체예로는 DIC제 폴리라이트(등록상표) OD-X-2155, OD-X-640, OD-X-2568, 다이셀화학제 프락셀(プラクセル)(등록상표) 205, L205AL, 205U, 208, 210, 212, L212AL, 220, 230, 240, 303, 305, 308, 312, 320 등을 들 수 있다.(B) As a polycaprolactone polyol which is a preferable example of the specific polymer of component, what carried out ring-opening polymerization of epsilon caprolactam using polyhydric alcohols, such as trimethylol propane and ethylene glycol, as an initiator is mentioned. Specific examples of polycaprolactone polyol include DIC's Polylite (registered trademark) OD-X-2155, OD-X-640, OD-X-2568, Daicel Chemical's Fraxel (registered trademark) 205, L205AL , 205U, 208, 210, 212, L212AL, 220, 230, 240, 303, 305, 308, 312, 320, and the like.
(B)성분의 특정중합체의 바람직한 일례인 폴리카보네이트폴리올로는, 트리메틸올프로판이나 에틸렌글리콜 등의 다가알코올에 탄산디에틸, 탄산디페닐, 에틸렌카보네이트 등을 반응시킨 것을 들 수 있다. 폴리카보네이트폴리올의 구체예로는 다이셀화학제 프락셀(등록상표) CD205, CD205PL, CD210, CD220, C-590, C-1050, C-2050, C-2090, C-3090 등을 들 수 있다.(B) As a polycarbonate polyol which is a preferable example of the specific polymer of component, what made diethyl carbonate, diphenyl carbonate, ethylene carbonate, etc. react with polyhydric alcohols, such as trimethylol propane and ethylene glycol, is mentioned. Specific examples of the polycarbonate polyol include Fraxel (registered trademark) CD205, CD205PL, CD210, CD220, C-590, C-1050, C-2050, C-2090, C-3090 manufactured by Daicel Chemicals.
(B)성분의 특정중합체의 바람직한 일례인 셀룰로오스로는, 하이드록시에틸셀룰로오스, 하이드록시프로필셀룰로오스 등의 하이드록시알킬셀룰로오스류, 하이드록시에틸메틸셀룰로오스, 하이드록시프로필메틸셀룰로오스, 하이드록시에틸에틸셀룰로오스 등의 하이드록시알킬알킬셀룰로오스류 및 셀룰로오스 등을 들 수 있고, 예를 들어, 하이드록시에틸셀룰로오스, 하이드록시프로필셀룰로오스 등의 하이드록시알킬셀룰로오스류가 바람직하다.(B) As a cellulose which is a preferable example of the specific polymer of component, hydroxyalkyl celluloses, such as hydroxyethyl cellulose and hydroxypropyl cellulose, hydroxyethyl methyl cellulose, hydroxypropyl methyl cellulose, hydroxyethyl ethyl cellulose, etc. of hydroxyalkylalkyl celluloses and cellulose, and for example, hydroxyalkyl celluloses such as hydroxyethyl cellulose and hydroxypropyl cellulose are preferable.
(B)성분의 특정중합체의 바람직한 일례인 시클로덱스트린으로는, α-시클로덱스트린, β-시클로덱스트린 및 γ-시클로덱스트린 등의 시클로덱스트린, 메틸-α-시클로덱스트린, 메틸-β-시클로덱스트린 그리고 메틸-γ-시클로덱스트린 등의 메틸화시클로덱스트린, 하이드록시메틸-α-시클로덱스트린, 하이드록시메틸-β-시클로덱스트린, 하이드록시메틸-γ-시클로덱스트린, 2-하이드록시에틸-α-시클로덱스트린, 2-하이드록시에틸-β-시클로덱스트린, 2-하이드록시에틸-γ-시클로덱스트린, 2-하이드록시프로필-α-시클로덱스트린, 2-하이드록시프로필-β-시클로덱스트린, 2-하이드록시프로필-γ-시클로덱스트린, 3-하이드록시프로필-α-시클로덱스트린, 3-하이드록시프로필-β-시클로덱스트린, 3-하이드록시프로필-γ-시클로덱스트린, 2,3-디하이드록시프로필-α-시클로덱스트린, 2,3-디하이드록시프로필-β-시클로덱스트린, 2,3-디하이드록시프로필-γ-시클로덱스트린 등의 하이드록시알킬시클로덱스트린 등을 들 수 있다.(B) As a cyclodextrin which is a preferable example of the specific polymer of component, Cyclodextrin, such as alpha-cyclodextrin, beta-cyclodextrin, and gamma-cyclodextrin, methyl-alpha-cyclodextrin, methyl- beta-cyclodextrin, and methyl Methylated cyclodextrin such as -γ-cyclodextrin, hydroxymethyl-α-cyclodextrin, hydroxymethyl-β-cyclodextrin, hydroxymethyl-γ-cyclodextrin, 2-hydroxyethyl-α-cyclodextrin, 2 -Hydroxyethyl-β-cyclodextrin, 2-hydroxyethyl-γ-cyclodextrin, 2-hydroxypropyl-α-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin, 2-hydroxypropyl-γ -Cyclodextrin, 3-hydroxypropyl-α-cyclodextrin, 3-hydroxypropyl-β-cyclodextrin, 3-hydroxypropyl-γ-cyclodextrin, 2,3-dihydroxypropyl-α-cyclodextrin and hydroxyalkyl cyclodextrins such as 2,3-dihydroxypropyl-β-cyclodextrin and 2,3-dihydroxypropyl-γ-cyclodextrin.
(B)성분의 특정중합체의 바람직한 일례인 멜라민포름알데히드 수지로는 멜라민과 포름알데히드를 중축합하여 얻어지는 수지이며 하기 식으로 표시된다.As a melamine-formaldehyde resin which is a preferable example of the specific polymer of (B) component, it is resin obtained by polycondensing melamine and formaldehyde, and is represented by a following formula.
[화학식 4][Formula 4]
상기 식 중, R은 수소원자 또는 탄소원자수 1 내지 4의 알킬기를 나타낸다.In the formula, R represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms.
(B)성분의 멜라민포름알데히드 수지는, 보존안정성의 관점에서 멜라민과 포름알데히드의 중축합시에 생성된 메틸올기가 알킬화되어 있는 것이 바람직하다.As for the melamine formaldehyde resin of (B) component, it is preferable that the methylol group produced|generated at the time of polycondensation of melamine and formaldehyde from a viewpoint of storage stability is alkylated.
(B)성분의 멜라민포름알데히드 수지를 얻는 방법은 특별히는 한정되지 않으나, 일반적으로 멜라민과 포름알데히드를 혼합하고, 탄산나트륨이나 암모니아 등을 이용하여 약알칼리성으로 한 후 60-100℃에서 가열함으로써 합성된다. 다시 알코올과 반응시킴으로써 메틸올기를 알콕시화할 수 있다.The method for obtaining the melamine formaldehyde resin of component (B) is not particularly limited, but generally it is synthesized by mixing melamine and formaldehyde, making it slightly alkaline using sodium carbonate or ammonia, and then heating at 60-100 ° C. . The methylol group can be alkoxylated by reacting again with an alcohol.
(B)성분의 멜라민포름알데히드 수지는, 중량평균분자량이 250 내지 5,000인 것이 바람직하고, 300 내지 4,000인 것이 보다 바람직하고, 350 내지 3,500인 것이 더욱 바람직하다. 중량평균분자량이 5,000을 초과하여 과대한 것이면, 용제에 대한 용해성이 저하되어 핸들링성이 저하되는 경우가 있고, 중량평균분자량이 250 미만으로 과소한 것이면, 열경화시에 경화부족이 되어 용제내성 및 내열성이 저하되는 경우가 있다.(B) It is preferable that weight average molecular weights are 250-5,000, As for the melamine formaldehyde resin of a component, it is more preferable that it is 300-4,000, It is more preferable that it is 350-3,500. If the weight average molecular weight exceeds 5,000 and is excessive, the solubility in solvents may decrease and handleability may decrease. If the weight average molecular weight is too small, the weight average molecular weight is less than 250. Heat resistance may fall.
본 발명에 있어서는, (B)성분의 멜라민포름알데히드 수지는 액체형태로, 혹은 정제한 액체를 후술하는 용제에 재용해한 용액형태로 이용할 수도 있다.In this invention, the melamine formaldehyde resin of (B) component can also be used with the liquid form or the solution form which re-dissolved the refined liquid in the solvent mentioned later.
또한, 본 발명에 있어서는, (B)성분의 멜라민포름알데히드 수지는, 복수종의 (B)성분의 멜라민포름알데히드 수지의 혼합물일 수도 있다.Moreover, in this invention, the mixture of the melamine formaldehyde resin of multiple types (B) component may be sufficient as the melamine formaldehyde resin of (B) component.
(B)성분의 특정중합체의 바람직한 일례인 페놀노볼락 수지로는, 예를 들어, 페놀-포름알데히드중축합물 등을 들 수 있다.(B) As a phenol novolak resin which is a preferable example of the specific polymer of component, a phenol- formaldehyde polycondensate etc. are mentioned, for example.
본 실시의 형태의 경화막 형성 조성물에 있어서, (B)성분의 폴리머는, 분체형태로, 또는 정제한 분말을 후술하는 용제에 재용해한 용액형태로 이용할 수도 있다.Cured film formation composition of this embodiment WHEREIN: The polymer of (B) component can also be used in the form of a solution which melt|dissolved again in the solvent mentioned later in the form of powder or refined powder.
또한, 본 실시의 형태의 경화막 형성 조성물에 있어서, (B)성분의 폴리머는, (B)성분의 폴리머의 복수종의 혼합물일 수도 있다.In addition, the cured film formation composition of this embodiment WHEREIN: The mixture of multiple types of the polymer of (B) component may be sufficient as the polymer of (B) component.
<(C)성분><(C)component>
본 실시의 형태의 경화막 형성 조성물에 함유되는 (C)성분은, N-하이드록시메틸 화합물 또는 N-알콕시메틸(메트)아크릴아미드 화합물을 포함하는 모노머를 중합한 폴리머이다.(C)component contained in the cured film formation composition of this embodiment is the polymer which superposed|polymerized the monomer containing an N-hydroxymethyl compound or N-alkoxymethyl (meth)acrylamide compound.
그러한 폴리머로는, N-알콕시메틸아크릴아미드 또는 N-하이드록시메틸아크릴아미드 등의 모노머를 단독 또는 공중합가능한 모노머와 공중합한 폴리머를 들 수 있다. 이러한 폴리머로는, 예를 들어, 폴리(N-부톡시메틸아크릴아미드), 폴리(N-에톡시메틸아크릴아미드), 폴리(N-메톡시메틸아크릴아미드), 폴리(N-하이드록시메틸아크릴아미드), N-부톡시메틸아크릴아미드와 스티렌과의 공중합체, N-부톡시메틸아크릴아미드와 메틸메타크릴레이트와의 공중합체, N-에톡시메틸메타크릴아미드와 벤질메타크릴레이트와의 공중합체, 및 N-부톡시메틸아크릴아미드와 벤질메타크릴레이트와 2-하이드록시프로필메타크릴레이트와의 공중합체 등을 들 수 있다. 이러한 폴리머의 중량평균분자량은, 1,000 내지 500,000이고, 바람직하게는, 2,000 내지 200,000이고, 보다 바람직하게는 3,000 내지 150,000이고, 더욱 바람직하게는 3,000 내지 50,000이다.Examples of such a polymer include a polymer obtained by copolymerizing a monomer such as N-alkoxymethylacrylamide or N-hydroxymethylacrylamide alone or with a copolymerizable monomer. Examples of such polymers include poly(N-butoxymethylacrylamide), poly(N-ethoxymethylacrylamide), poly(N-methoxymethylacrylamide), poly(N-hydroxymethylacrylamide), and poly(N-hydroxymethylacrylamide). amide), a copolymer of N-butoxymethylacrylamide and styrene, a copolymer of N-butoxymethylacrylamide and methyl methacrylate, and a copolymer of N-ethoxymethylmethacrylamide and benzyl methacrylate Copolymers and copolymers of N-butoxymethylacrylamide, benzyl methacrylate and 2-hydroxypropyl methacrylate, and the like are mentioned. The polymer has a weight average molecular weight of 1,000 to 500,000, preferably, 2,000 to 200,000, more preferably 3,000 to 150,000, and still more preferably 3,000 to 50,000.
이들 (C)성분의 폴리머는, 단독으로 또는 2종 이상을 조합하여 사용할 수 있다.The polymer of these (C)component can be used individually or in combination of 2 or more type.
본 실시의 형태의 경화막 형성 조성물에 있어서의 (C)성분의 N-하이드록시메틸 화합물 또는 N-알콕시메틸(메트)아크릴아미드 화합물을 포함하는 모노머를 중합한 폴리머의 함유량은, (A)성분인 화합물과 (B)성분의 폴리머의 합계량인 100질량부에 기초하여 10질량부 내지 150질량부인 것이 바람직하고, 보다 바람직하게는 20질량부 내지 100질량부이다. (C)성분의 N-하이드록시메틸 화합물 또는 N-알콕시메틸(메트)아크릴아미드 화합물을 포함하는 모노머를 중합한 폴리머의 함유량이 과소한 경우에는, 경화막 형성 조성물로부터 얻어지는 경화막의 용제내성 및 내열성이 저하되어, 광배향시의 감도가 저하된다. 한편, 함유량이 과대한 경우에는 광배향성 및 보존안정성이 저하되는 경우가 있다.Content of the polymer which superposed|polymerized the monomer containing the N-hydroxymethyl compound or N-alkoxymethyl (meth)acrylamide compound of (C)component in the cured film formation composition of this embodiment is (A) component Based on 100 mass parts which is the total amount of the polymer of a phosphorus compound and (B) component, it is preferable that they are 10 mass parts - 150 mass parts, More preferably, they are 20 mass parts - 100 mass parts. (C) When content of the polymer which superposed|polymerized the monomer containing N-hydroxymethyl compound or N-alkoxymethyl (meth)acrylamide compound of component is too little, solvent resistance and heat resistance of the cured film obtained from a cured film formation composition This falls, and the sensitivity at the time of optical alignment falls. On the other hand, when the content is excessive, the optical orientation and storage stability may decrease.
<(D)성분><(D)component>
본 실시의 형태의 경화막 형성 조성물은, (A)성분, (B)성분, (C)성분에 더하여, 추가로, (D)성분으로서 가교촉매를 함유한다.In addition to (A) component, (B) component, and (C)component, the cured film formation composition of this embodiment contains a crosslinking catalyst as (D)component further.
(D)성분인 가교촉매로는, 예를 들어, 산 또는 열산발생제로 할 수 있다. 이 (D)성분은, 본 실시의 형태의 경화막 형성 조성물의 열경화반응을 촉진시키는데 있어서 유효하다.(D) As a crosslinking catalyst which is a component, it can be set as an acid or a thermal acid generator, for example. When this (D)component accelerates|stimulates the thermosetting reaction of the cured film formation composition of this embodiment, it is effective.
(D)성분으로는, 설폰산기함유 화합물, 염산 또는 그의 염, 및 프리베이크 또는 포스트베이크시에 열분해하여 산을 발생하는 화합물, 즉 온도 80℃ 내지 250℃에서 열분해하여 산을 발생하는 화합물이면 특별히 한정되는 것은 아니다. 그러한 화합물로는, 예를 들어, 염산, 메탄설폰산, 에탄설폰산, 프로판설폰산, 부탄설폰산, 펜탄설폰산, 옥탄설폰산, 벤젠설폰산, p-톨루엔설폰산, 캠퍼설폰산, 트리플루오로메탄설폰산, p-페놀설폰산, 2-나프탈렌설폰산, 메시틸렌설폰산, p-자일렌-2-설폰산, m-자일렌-2-설폰산, 4-에틸벤젠설폰산, 1H,1H,2H,2H-퍼플루오로옥탄설폰산, 퍼플루오로(2-에톡시에탄)설폰산, 펜타플루오로에탄설폰산, 노나플루오로부탄-1-설폰산, 도데실벤젠설폰산 등의 설폰산 또는 그의 수화물이나 염 등을 들 수 있다. 열에 의해 산을 발생하는 화합물로는, 예를 들어, 비스(토실옥시)에탄, 비스(토실옥시)프로판, 비스(토실옥시)부탄, p-니트로벤질토실레이트, o-니트로벤질토실레이트, 1,2,3-페닐렌트리스(메틸설포네이트), p-톨루엔설폰산피리디늄염, p-톨루엔설폰산모르포늄염, p-톨루엔설폰산에틸에스테르, p-톨루엔설폰산프로필에스테르, p-톨루엔설폰산부틸에스테르, p-톨루엔설폰산이소부틸에스테르, p-톨루엔설폰산메틸에스테르, p-톨루엔설폰산페네틸에스테르, 시아노메틸p-톨루엔설포네이트, 2,2,2-트리플루오로에틸p-톨루엔설포네이트, 2-하이드록시부틸p-톨루엔설포네이트, N-에틸-p-톨루엔설폰아미드, 및 하기 식으로 표시되는 화합물 등을 들 수 있다.(D) As the component, a sulfonic acid group-containing compound, hydrochloric acid or a salt thereof, and a compound that thermally decomposes to generate an acid during pre-baking or post-baking, that is, a compound that generates an acid by thermal decomposition at a temperature of 80°C to 250°C. It is not limited. Such compounds include, for example, hydrochloric acid, methanesulfonic acid, ethanesulfonic acid, propanesulfonic acid, butanesulfonic acid, pentanesulfonic acid, octanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, tri Fluoromethanesulfonic acid, p-phenolsulfonic acid, 2-naphthalenesulfonic acid, mesitylenesulfonic acid, p-xylene-2-sulfonic acid, m-xylene-2-sulfonic acid, 4-ethylbenzenesulfonic acid, 1H,1H,2H,2H-Perfluorooctanesulfonic acid, perfluoro(2-ethoxyethane)sulfonic acid, pentafluoroethanesulfonic acid, nonafluorobutane-1-sulfonic acid, dodecylbenzenesulfonic acid Sulfonic acids, such as sulfonic acids, its hydrate, salt, etc. are mentioned. As a compound which generates an acid by heat, for example, bis(tosyloxy)ethane, bis(tosyloxy)propane, bis(tosyloxy)butane, p-nitrobenzyltosylate, o-nitrobenzyltosylate, 1 ,2,3-phenylentris (methylsulfonate), p-toluenesulfonic acid pyridinium salt, p-toluenesulfonic acid morphonium salt, p-toluenesulfonic acid ethyl ester, p-toluenesulfonic acid propyl ester, p-toluenesulfonate Butyl ester, p-toluenesulfonic acid isobutyl ester, p-toluenesulfonic acid methyl ester, p-toluenesulfonic acid phenethyl ester, cyanomethyl p-toluenesulfonate, 2,2,2-trifluoroethyl p- Toluenesulfonate, 2-hydroxybutylp-toluenesulfonate, N-ethyl-p-toluenesulfonamide, and the compound represented by the following formula, etc. are mentioned.
[화학식 5][Formula 5]
[화학식 6][Formula 6]
[화학식 7][Formula 7]
[화학식 8][Formula 8]
[화학식 9][Formula 9]
[화학식 10][Formula 10]
본 실시의 형태의 경화막 형성 조성물에 있어서의 (D)성분의 함유량은, (A)성분의 화합물과 (B)성분의 폴리머의 합계량인 100질량부에 대해, 바람직하게는 0.01질량부 내지 10질량부, 보다 바람직하게는 0.1질량부 내지 6질량부, 더욱 바람직하게는 0.5질량부 내지 5질량부이다. (D)성분의 함유량을 0.01질량부 이상으로 함으로써, 충분한 열경화성 및 용제내성을 부여할 수 있고, 나아가 광조사에 대한 높은 감도도 부여할 수 있다.With respect to 100 mass parts which content of (D)component in the cured film formation composition of this embodiment is the total amount of the compound of (A) component, and the polymer of (B)component, Preferably 0.01 mass part - 10 It is a mass part, More preferably, it is 0.1 mass part - 6 mass parts, More preferably, it is 0.5 mass part - 5 mass parts. (D) By making content of component into 0.01 mass part or more, sufficient thermosetting and solvent tolerance can be provided, and the high sensitivity with respect to light irradiation can also be provided.
<(E)성분><(E) component>
본 발명의 경화막 형성 조성물은 (E)성분으로서, 형성되는 경화막의 접착성을 향상시키는 성분(이하, 밀착향상성분이라고도 한다.)을 함유할 수도 있다.The cured film formation composition of this invention may contain the component (henceforth a close_contact|adherence improving component.) which improves the adhesiveness of the cured film formed as (E) component.
(E)성분인 밀착향상성분은, 본 발명의 경화막 형성 조성물로부터 얻어지는 배향재와 중합성 액정의 층과의 밀착성이 향상되도록, 중합성 액정의 중합성 관능기와 배향재의 가교반응부위를 공유결합에 의해 링크시킬 수 있다. 그 결과, 본 실시형태의 배향재 상에 경화된 중합성 액정을 적층하여 이루어지는 본 실시형태의 위상차재는, 고온고습의 조건하에서도, 강한 밀착성을 유지할 수 있고, 박리 등에 대한 높은 내구성을 나타낼 수 있다.(E) The adhesion-improving component is a covalent bond between the polymerizable functional group of the polymerizable liquid crystal and the cross-linking reaction site of the alignment material so that the adhesion between the layer of the polymerizable liquid crystal and the alignment material obtained from the cured film forming composition of the present invention is improved. can be linked by As a result, the retardation material of this embodiment formed by laminating a cured polymerizable liquid crystal on the alignment material of this embodiment can maintain strong adhesiveness even under conditions of high temperature and high humidity, and can exhibit high durability against peeling etc. .
(E)성분으로는, 하이드록시기 및 N-알콕시메틸기로부터 선택되는 기와, 중합성기를 갖는 모노머 및 폴리머가 바람직하다.(E) As a component, the monomer and polymer which have group chosen from a hydroxyl group and N-alkoxy methyl group, and a polymeric group are preferable.
이러한 (E)성분으로는, 하이드록시기와 (메트)아크릴기를 갖는 화합물, N-알콕시메틸기와 (메트)아크릴기를 갖는 화합물, N-알콕시메틸기와 (메트)아크릴기를 갖는 폴리머 등을 들 수 있다. 이하, 각각 구체예를 나타낸다.As such component (E), the compound which has a hydroxyl group and a (meth)acryl group, the compound which has an N-alkoxymethyl group and a (meth)acryl group, the polymer etc. which have an N-alkoxymethyl group and a (meth)acryl group are mentioned. Hereinafter, each specific example is shown.
(E)성분의 일례로서, 하이드록시기를 함유한 다관능 아크릴레이트(이하, 하이드록시기함유 다관능 아크릴레이트라고도 한다.)를 들 수 있다.(E) As an example of a component, the polyfunctional acrylate containing a hydroxyl group (henceforth, it is also mentioned hydroxyl-group containing polyfunctional acrylate.) is mentioned.
(E)성분의 예인 하이드록시기함유 다관능 아크릴레이트로는, 예를 들어, 펜타에리스리톨트리아크릴레이트 및 디펜타에리스리톨펜타아크릴레이트 등을 들 수 있다.(E) As a hydroxyl-group containing polyfunctional acrylate which is an example of a component, pentaerythritol triacrylate, dipentaerythritol pentaacrylate, etc. are mentioned, for example.
(E)성분의 일례로서, 1개의 아크릴기와, 1개 이상의 하이드록시기를 갖는 화합물도 들 수 있다.(E) As an example of a component, the compound which has one acryl group and one or more hydroxyl groups is also mentioned.
또한, (E)성분의 화합물로는, 1분자 중에 C=C이중결합을 포함하는 중합성기를 적어도 1개와, N-알콕시메틸기를 적어도 1개 갖는 화합물을 들 수 있다.Moreover, as a compound of (E)component, the compound which has at least 1 polymerizable group containing a C=C double bond in 1 molecule, and at least 1 N-alkoxymethyl group is mentioned.
C=C이중결합을 포함하는 중합성기로는, 아크릴기, 메타크릴기, 비닐기, 알릴기, 말레이미드기 등을 들 수 있다.Examples of the polymerizable group containing a C=C double bond include an acryl group, a methacryl group, a vinyl group, an allyl group, and a maleimide group.
1분자 중에 C=C이중결합을 포함하는 중합성기를 적어도 1개와, N-알콕시메틸기를 적어도 1개 갖는 화합물로는, 바람직하게는, 예를 들어 하기의 식(X1)로 표시되는 화합물을 들 수 있다.As the compound having at least one polymerizable group containing a C=C double bond and at least one N-alkoxymethyl group in one molecule, preferably, for example, a compound represented by the following formula (X1) is exemplified can
[화학식 11][Formula 11]
(식 중, R31은 수소원자 또는 메틸기를 나타내고, R32는 수소원자, 혹은 직쇄 또는 분지의 탄소원자수 1 내지 10의 알킬기를 나타낸다)(Wherein, R 31 represents a hydrogen atom or a methyl group, and R 32 represents a hydrogen atom or a linear or branched alkyl group having 1 to 10 carbon atoms)
상기 식(X1)로 표시되는 화합물의 구체예로는, N-하이드록시메틸(메트)아크릴아미드, N-메톡시메틸(메트)아크릴아미드, N-에톡시메틸(메트)아크릴아미드, N-부톡시메틸(메트)아크릴아미드 등의 하이드록시메틸기 또는 알콕시메틸기로 치환된 아크릴아미드 화합물 또는 메타크릴아미드 화합물을 들 수 있다. 한편 (메트)아크릴아미드란 메타크릴아미드와 아크릴아미드의 쌍방을 의미한다.Specific examples of the compound represented by the formula (X1) include N-hydroxymethyl (meth)acrylamide, N-methoxymethyl (meth)acrylamide, N-ethoxymethyl (meth)acrylamide, N- and acrylamide compounds or methacrylamide compounds substituted with hydroxymethyl groups or alkoxymethyl groups, such as butoxymethyl (meth)acrylamide. On the other hand, (meth)acrylamide means both methacrylamide and acrylamide.
(E)성분의 C=C이중결합을 포함하는 중합성기와 N-알콕시메틸기를 갖는 화합물의 다른 태양으로는, 바람직하게는, 예를 들어 하기의 화합물을 들 수 있다.(E) As another aspect of the compound which has a polymeric group containing C=C double bond of component and N-alkoxymethyl group, Preferably, the following compound is mentioned, for example.
[화학식 12][Formula 12]
본 발명의 실시형태의 액정배향제에 있어서의 (E)성분의 함유량은, (A)성분인 배향성분의 100질량부에 대해, 바람직하게는 1질량부~100질량부이고, 더욱 바람직하게는 5질량부~70질량부이다.To 100 mass parts of the orientation component which is (A) component, content of (E) component in the liquid crystal aligning agent of embodiment of this invention becomes like this. Preferably it is 1 mass part - 100 mass parts, More preferably It is 5 mass parts - 70 mass parts.
<용제><solvent>
본 실시의 형태의 경화막 형성 조성물은, 주로 용제에 용해된 용액상태로 이용된다. 그때에 사용하는 용제는, 탄소수 1~4의 지방산의 탄소수 1~4알킬에스테르를 포함하는 것이며, (A)성분, (B)성분 및 (C)성분, 필요에 따라 (D)성분, 및/또는, 후술하는 기타 첨가제를 용해할 수 있는 것이면 되고, 그 밖의 조성, 종류 등은 특별히 한정되는 것은 아니다.The cured film formation composition of this embodiment is mainly used in the solution state melt|dissolved in the solvent. The solvent used in that case contains a C1-C4 alkylester of a C1-C4 fatty acid, (A) component, (B) component, and (C)component, as needed (D)component, and/ Alternatively, other additives described later may be dissolved therein, and other compositions, types, and the like are not particularly limited.
탄소수 1~4의 지방산의 탄소수 1~4알킬에스테르로는, 식: R1COOR2(단, R1은 수소원자 혹은 탄소수가 바람직하게는 1~4, 보다 바람직하게는 1 또는 2인 알킬기이고, R2는 탄소수가 1~4인 알킬기이다.)로 표시되는 지방산알킬에스테르가 호적하다. 바람직한 구체예로는, 포름산메틸, 포름산에틸, 포름산n-프로필, 포름산i-프로필, 포름산n-부틸, 포름산i-부틸, 아세트산메틸, 아세트산에틸, 아세트산n-프로필, 아세트산i-프로필, 아세트산n-부틸, 아세트산i-부틸, 프로피온산메틸, 프로피온산에틸, 프로피온산n-프로필, 프로피온산i-프로필, 프로피온산n-부틸, 또는 프로피온산i-부틸을 들 수 있다. 특히, 아세트산메틸, 아세트산에틸, 아세트산n-프로필, 아세트산i-프로필, 아세트산n-부틸, 프로피온산메틸, 프로피온산에틸, 프로피온산n-프로필, 또는 프로피온산i-프로필이 바람직하다. 이들 중 1종 또는 2종 이상을 사용할 수 있다.As a C1-C4 alkylester of a C1-C4 fatty acid, Formula: R 1 COOR 2 (provided that R 1 is a hydrogen atom or an alkyl group having preferably 1 to 4 carbon atoms, more preferably 1 or 2 carbon atoms, , R 2 is an alkyl group having 1 to 4 carbon atoms). Preferred examples include methyl formate, ethyl formate, n-propyl formate, i-propyl formate, n-butyl formate, i-butyl formate, methyl acetate, ethyl acetate, n-propyl acetate, i-propyl acetate, n acetate -butyl, i-butyl acetate, methyl propionate, ethyl propionate, n-propyl propionate, i-propyl propionate, n-butyl propionate, or i-butyl propionate. In particular, methyl acetate, ethyl acetate, n-propyl acetate, i-propyl acetate, n-butyl acetate, methyl propionate, ethyl propionate, n-propyl propionate, or i-propyl propionate are preferable. One type or two or more types of these can be used.
탄소수 1~5의 알코올로는, 메탄올, 에탄올, n-프로판올, i-프로판올, n-부탄올, s-부탄올, t-부탄올, n-펜탄올 등을 들 수 있다. 이 중에서도, 1급 및 2급의 알코올이, 캡핑이 쉽다는 점에서 바람직하다.Examples of the alcohol having 1 to 5 carbon atoms include methanol, ethanol, n-propanol, i-propanol, n-butanol, s-butanol, t-butanol, and n-pentanol. Among these, primary and secondary alcohols are preferable from the viewpoint of easy capping.
또한, 본원발명의 경화막 형성 조성물은, 탄소수 1~5의 알코올과, 탄소수 1~4의 지방산의 탄소수 1~4알킬에스테르 이외에, 기타 용제를 함유하고 있을 수도 있다.Moreover, the cured film formation composition of this invention may contain other solvent other than C1-C5 alcohol and C1-C4 alkylester of a C1-C4 fatty acid.
기타 용제의 구체예로는, 예를 들어, 에틸렌글리콜모노메틸에테르, 에틸렌글리콜모노에틸에테르, 메틸셀로솔브아세테이트, 에틸셀로솔브아세테이트, 디에틸렌글리콜모노메틸에테르, 디에틸렌글리콜모노에틸에테르, 프로필렌글리콜, 프로필렌글리콜모노메틸에테르, 프로필렌글리콜모노메틸에테르아세테이트, 프로필렌글리콜프로필에테르아세테이트, 톨루엔, 자일렌, 메틸에틸케톤, 시클로펜탄온, 시클로헥사논, 2-부탄온, 3-메틸-2-펜탄온, 2-펜탄온, 2-헵탄온, γ-부티로락톤, 2-하이드록시프로피온산에틸, 2-하이드록시-2-메틸프로피온산에틸, 에톡시아세트산에틸, 하이드록시아세트산에틸, 2-하이드록시-3-메틸부탄산메틸, 3-메톡시프로피온산메틸, 3-메톡시프로피온산에틸, 3-에톡시프로피온산에틸, 3-에톡시프로피온산메틸, 피루브산메틸, 피루브산에틸, 유산에틸, 유산부틸, N,N-디메틸포름아미드, N,N-디메틸아세트아미드, 및 N-메틸피롤리돈 등을 들 수 있다.Specific examples of other solvents include, for example, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, Propylene glycol, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol propyl ether acetate, toluene, xylene, methyl ethyl ketone, cyclopentanone, cyclohexanone, 2-butanone, 3-methyl-2- Pentanone, 2-pentanone, 2-heptanone, γ-butyrolactone, ethyl 2-hydroxypropionate, 2-hydroxy-2-methylpropionate ethyl, ethoxyethyl acetate, ethyl hydroxyacetate, 2-hydroxyl Methyl hydroxy-3-methylbutanoate, methyl 3-methoxypropionate, ethyl 3-methoxypropionate, ethyl 3-ethoxypropionate, methyl 3-ethoxypropionate, methyl pyruvate, ethyl pyruvate, ethyl lactate, butyl lactate, N and N-dimethylformamide, N,N-dimethylacetamide, and N-methylpyrrolidone.
이들 용제는, 1종 단독으로 또는 2종 이상의 조합으로 사용할 수 있다.These solvents can be used individually by 1 type or in combination of 2 or more types.
<기타 첨가제><Other additives>
추가로, 본 실시의 형태의 경화막 형성 조성물은, 본 발명의 효과를 손상시키지 않는 한, 필요에 따라, 증감제, 실란커플링제, 계면활성제, 레올로지조정제, 안료, 염료, 보존안정제, 소포제, 산화방지제 등을 함유할 수 있다.Furthermore, the cured film formation composition of this embodiment is a sensitizer, a silane coupling agent, surfactant, a rheology modifier, a pigment, dye, a storage stabilizer, and an antifoamer as needed unless the effect of this invention is impaired. , antioxidants and the like.
예를 들어, 증감제는, 본 실시의 형태의 경화막 형성 조성물을 이용하여 열경화막을 형성한 후, 광반응을 촉진하는데 있어서 유효하다.For example, a sensitizer is effective in promoting a photoreaction, after forming a thermosetting film using the cured film formation composition of this embodiment.
기타 첨가제의 일례인 증감제로는, 벤조페논, 안트라센, 안트라퀴논, 티옥산톤 등 및 그의 유도체, 그리고 니트로페닐 화합물 등을 들 수 있다. 이들 중, 벤조페논유도체 및 니트로페닐 화합물이 바람직하다. 바람직한 화합물의 구체예로서 N,N-디에틸아미노벤조페논, 2-니트로플루오렌, 2-니트로플루오레논, 5-니트로아세나프텐, 4-니트로비페닐, 4-니트로계피산, 4-니트로스틸벤, 4-니트로벤조페논, 5-니트로인돌 등을 들 수 있다. 특히, 벤조페논의 유도체인 N,N-디에틸아미노벤조페논이 바람직하다.As a sensitizer which is an example of another additive, benzophenone, anthracene, anthraquinone, thioxanthone, etc. and its derivative(s), a nitrophenyl compound, etc. are mentioned. Among these, benzophenone derivatives and nitrophenyl compounds are preferable. Specific examples of preferred compounds include N,N-diethylaminobenzophenone, 2-nitrofluorene, 2-nitrofluorenone, 5-nitroacenaphthene, 4-nitrobiphenyl, 4-nitrocinnamic acid, 4-nitrostilbene, 4-nitrobenzophenone, 5-nitroindole, etc. are mentioned. In particular, N,N-diethylaminobenzophenone which is a derivative of benzophenone is preferable.
이들 증감제는 상기의 것으로 한정되는 것은 아니다. 또한, 증감제는 단독으로 또는 2종 이상의 화합물을 조합하여 병용하는 것이 가능하다.These sensitizers are not limited to said thing. In addition, a sensitizer can be used individually or in combination of 2 or more types of compounds.
본 실시의 형태의 경화막 형성 조성물에 있어서의 증감제의 사용비율은, (A)성분의 특정공중합체와 (B)성분의 아크릴중합체의 합계질량인 100질량부에 대해 0.1질량부 내지 20질량부인 것이 바람직하고, 보다 바람직하게는 0.2질량부 내지 10질량부이다. 이 비율이 과소한 경우에는, 증감제로서의 효과를 충분히 얻지 못하는 경우가 있고, 과대한 경우에는 투과율의 저하 및 도막의 거칠어짐이 발생하는 경우가 있다.The use ratio of the sensitizer in the cured film formation composition of this embodiment is 0.1 mass part - 20 mass with respect to 100 mass parts which is the total mass of the specific copolymer of (A) component, and the acrylic polymer of (B) component It is preferable that it is negative, More preferably, it is 0.2 mass part - 10 mass parts. When this ratio is too little, the effect as a sensitizer may not fully be acquired, and when excessive, the fall of the transmittance|permeability and the roughening of a coating film may generate|occur|produce.
<경화막 형성 조성물의 조제><Preparation of a cured film forming composition>
본 실시의 형태의 경화막 형성 조성물은, (A)광배향성기와 하이드록시기, 카르복실기 및 아미노기로부터 선택되는 어느 1개의 치환기를 갖는 화합물, (B)하이드록시기, 카르복실기 및 아미노기로부터 선택되는 1종 또는 2종 이상의 치환기를 갖는 친수성 폴리머, (C)N-하이드록시메틸 화합물 또는 N-알콕시메틸(메트)아크릴아미드 화합물을 포함하는 모노머를 중합한 폴리머, (D)가교촉매, 그리고, 탄소수 1~5의 알코올과, 탄소수 1~4의 지방산의 탄소수 1~4알킬에스테르와의 쌍방을 포함하는 용제를 함유한다. 그리고, 본 발명의 효과를 손상시키지 않는 한, 기타 첨가제를 함유할 수 있다.The cured film formation composition of this embodiment is (A) the compound which has any one substituent chosen from a photo-alignment group, a hydroxyl group, a carboxyl group, and an amino group, (B) 1 type chosen from a hydroxyl group, a carboxyl group, and an amino group or a hydrophilic polymer having two or more substituents, (C) a polymer obtained by polymerizing a monomer containing a N-hydroxymethyl compound or an N-alkoxymethyl (meth)acrylamide compound, (D) a crosslinking catalyst, and a carbon number of 1 to The solvent containing both the alcohol of 5 and the C1-C4 alkylester of a C1-C4 fatty acid is contained. In addition, other additives may be contained as long as the effects of the present invention are not impaired.
(A)성분과 (B)성분의 배합비는, 액정배향성 및 용제내성의 점에서, 질량비로 5:95 내지 60:40이 바람직하다.(A) As for the compounding ratio of component and (B) component, 5:95-60:40 are preferable at the point of liquid-crystal orientation and solvent tolerance by mass ratio.
탄소수 1~5의 알코올용제와, 탄소수 1~4의 지방산의 탄소수 1~4알킬에스테르용제의 함유비율은, 질량비로 10:90~90:10인 것이 바람직하다. 또한, 상기 기타 용제를 함유하는 경우, 용제 전체에 차지하는 탄소수 1~5의 알코올용제와, 탄소수 1~4의 지방산의 탄소수 1~4알킬에스테르용제의 합계량이 30질량%~99질량%인 것이 바람직하다.It is preferable that the content ratio of a C1-C5 alcohol solvent and a C1-C4 fatty acid C1-C4 alkylester solvent is 10:90-90:10 by mass ratio. In addition, in the case of containing the above other solvents, it is preferable that the total amount of the alcohol solvent having 1 to 5 carbon atoms and the solvent having 1 to 4 carbon atoms of the fatty acid having 1 to 4 carbon atoms in the entire solvent is 30% by mass to 99% by mass. do.
본 실시의 형태의 경화막 형성 조성물을 용액으로서 이용하는 경우의 배합비율, 조제방법 등을 이하에 상세히 서술한다.The compounding ratio in the case of using the cured film formation composition of this embodiment as a solution, a preparation method, etc. are demonstrated in full detail below.
본 실시의 형태의 경화막 형성 조성물에 있어서의 고형분의 비율은, 각 성분이 균일하게 용제에 용해되어 있는 한, 특별히 한정되는 것은 아니나, 1질량% 내지 80질량%이고, 바람직하게는 3질량% 내지 60질량%이고, 보다 바람직하게는 5질량% 내지 40질량%이다. 여기서, 고형분이란, 경화막 형성 조성물의 전체성분에서 용제를 제외한 것을 말한다.Although the ratio of solid content in the cured film formation composition of this embodiment is not specifically limited as long as each component is melt|dissolving in the solvent uniformly, It is 1 mass % - 80 mass %, Preferably it is 3 mass % thru|or 60 mass %, More preferably, it is 5 mass % - 40 mass %. Here, solid content means what removed the solvent from all the components of a cured film formation composition.
본 실시의 형태의 경화막 형성 조성물의 조제방법은, 특별히 한정되지 않는다. 조제법으로는, 예를 들어, (B)성분이나 (C)성분에서 유래하는 용매에, (A)성분, 필요에 따라 (E)성분 등을 넣고, 탄소수 1~4의 지방산의 탄소수 1~4알킬에스테르를 넣고, 다음에 탄소수 1~5의 알코올용매를 넣은 후, (D)성분을 넣어, 균일한 용액으로 하는 방법, 혹은, 이 조제법의 적당한 단계에 있어서, 필요에 따라 (E)성분이나, 기타 첨가제를 추가로 첨가하여 혼합하는 방법을 들 수 있다.The preparation method of the cured film formation composition of this embodiment is not specifically limited. As a preparation method, (A) component, (E)component etc. are put into the solvent derived from (B) component or (C)component as needed, for example, and C1-C4 of a C1-C4 fatty acid After adding an alkyl ester, then adding an alcohol solvent having 1 to 5 carbon atoms, and then adding component (D) to make a uniform solution, or at an appropriate step of this preparation method, if necessary, component (E) or , and a method of mixing by additionally adding other additives.
또한, 조제된 경화막 형성 조성물의 용액은, 구명직경이 0.2μm 정도인 필터 등을 이용하여 여과한 후, 사용하는 것이 바람직하다.Moreover, it is preferable to use, after filtering the solution of the prepared cured film formation composition using the filter etc. whose hole diameter is about 0.2 micrometer.
<경화막, 배향재 및 위상차재><Cured film, alignment material and phase difference material>
본 실시의 형태의 경화막 형성 조성물의 용액을 기판(예를 들어, 실리콘/이산화실리콘피복기판, 실리콘나이트라이드기판, 금속, 예를 들어, 알루미늄, 몰리브덴, 크롬 등이 피복된 기판, 유리기판, 석영기판, ITO기판 등)이나 필름(예를 들어, 트리아세틸셀룰로오스(TAC)필름, 시클로올레핀폴리머필름, 폴리에틸렌테레프탈레이트필름, 아크릴필름 등의 수지필름) 등의 위에, 바코트, 회전도포, 흘림도포, 롤도포, 슬릿도포, 슬릿에 이은 회전도포, 잉크젯도포, 인쇄 등에 의해 도포하여 도막을 형성하고, 그 후, 핫플레이트 또는 오븐 등에서 가열건조함으로써, 경화막을 형성할 수 있다.The solution of the cured film forming composition of this embodiment is applied to a substrate (for example, a silicon/silicon dioxide coated substrate, a silicon nitride substrate, a metal, for example, a substrate coated with aluminum, molybdenum, chromium, etc., a substrate, a glass substrate, Quartz substrate, ITO substrate, etc.) or film (for example, triacetyl cellulose (TAC) film, cycloolefin polymer film, polyethylene terephthalate film, resin film such as acrylic film), etc. A cured film can be formed by coating, roll application, slit application, rotational application following the slit, inkjet application, printing, etc. to form a coating film, and then drying by heating on a hot plate or oven or the like.
가열건조의 조건으로는, 경화막으로 형성되는 배향재의 성분이, 그 위에 도포되는 중합성 액정용액에 용출되지 않을 정도로, 가교제에 의한 가교반응이 진행되면 되고, 예를 들어, 온도 60℃ 내지 200℃, 시간 0.4분간 내지 60분간의 범위 내에서 적당히 선택된 가열온도 및 가열시간이 채용된다. 가열온도 및 가열시간은, 바람직하게는 70℃ 내지 160℃, 0.5분간 내지 10분간이다.As the conditions for drying by heat, the crosslinking reaction by the crosslinking agent may proceed to such an extent that the component of the alignment material formed into the cured film does not elute to the polymerizable liquid crystal solution applied thereon, for example, at a temperature of 60°C to 200°C. A heating temperature and a heating time appropriately selected within the range of from 0.4 minutes to 60 minutes are employed. The heating temperature and the heating time are preferably 70°C to 160°C, 0.5 minutes to 10 minutes.
본 실시의 형태의 경화성 조성물을 이용하여 형성되는 경화막의 막두께는, 예를 들어, 0.05μm 내지 5μm이고, 사용하는 기판의 단차나 광학적, 전기적 성질을 고려하여 적당히 선택할 수 있다.The film thickness of the cured film formed using the curable composition of this embodiment is, for example, 0.05 micrometer - 5 micrometers, Considering the level|step difference of the board|substrate to be used, and an optical and electrical property, it can select suitably.
이렇게 하여 형성된 경화막은, 편광UV조사를 행함으로써 배향재, 즉, 액정 등의 액정성을 갖는 화합물을 배향시키는 부재로서 기능시킬 수 있다.The cured film formed in this way can function as an orientation material, ie, a member which orientates the compound which has liquid crystals, such as a liquid crystal, by performing polarization|polarized-light UV irradiation.
편광UV의 조사방법으로는, 통상 150nm 내지 450nm의 파장의 자외광 내지 가시광이 이용되며, 실온 또는 가열한 상태로 수직 또는 기울기방향으로부터 직선편광을 조사함으로써 행해진다.As a method of irradiating polarized UV, usually, ultraviolet light or visible light having a wavelength of 150 nm to 450 nm is used, and it is carried out by irradiating linearly polarized light from the perpendicular or oblique direction at room temperature or in a heated state.
본 실시형태의 경화막 조성물로 형성된 배향재는 내용제성 및 내열성을 갖고 있으므로, 이 배향재 상에, 중합성 액정용액으로 이루어지는 위상차재료를 도포한 후, 액정의 상전이온도까지 가열함으로써 위상차재료를 액정상태로 하고, 배향재 상에서 배향시킨다. 그리고, 배향상태가 된 위상차재료를 그대로 경화시켜, 광학이방성을 갖는 층으로서 위상차재를 형성할 수 있다.Since the orientation material formed from the cured film composition of this embodiment has solvent resistance and heat resistance, on this orientation material, after apply|coating the retardation material which consists of a polymeric liquid crystal solution, by heating to the phase transition temperature of a liquid crystal, the retardation material is liquid-crystal state and oriented on the orientation material. And the retardation material which became an orientation state can be hardened as it is, and the retardation material can be formed as a layer which has optical anisotropy.
위상차재료로는, 예를 들어, 중합성기를 갖는 액정모노머 및 그것을 함유하는 조성물 등이 이용된다. 그리고, 배향재를 형성하는 기판이 필름인 경우에는, 본 실시의 형태의 위상차재를 갖는 필름은, 위상차필름으로서 유용하다. 이러한 위상차재를 형성하는 위상차재료는, 액정상태가 되어, 배향재 상에서, 수평배향, 콜레스테릭배향, 수직배향, 하이브리드배향 등의 배향상태를 취하는 것이 있으며, 각각 필요시되는 위상차에 따라 구분하여 사용할 수 있다.As the retardation material, for example, a liquid crystal monomer having a polymerizable group and a composition containing the same are used. And when the board|substrate which forms an orientation material is a film, the film which has the retardation material of this embodiment is useful as retardation film. The retardation material forming such a retardation material is in a liquid crystal state, and there are some that take an orientation state such as horizontal orientation, cholesteric orientation, vertical orientation, hybrid orientation, etc. on the orientation material. Can be used.
또한, 3D디스플레이에 이용되는 패턴화 위상차재를 제조하는 경우에는, 본 실시형태의 경화막 조성물로부터 상기한 방법으로 형성된 경화막에, 라인앤스페이스패턴의 마스크를 통해 소정의 기준으로부터, 예를 들어, +45도의 방향으로 편광UV노광하고, 이어서, 마스크를 분리하고 나서 -45도의 방향으로 편광UV를 노광하고, 액정의 배향제어방향이 상이한 2종류의 액정배향영역이 형성된 배향재를 얻는다. 그 후, 중합성 액정용액으로 이루어지는 위상차재료를 도포한 후, 액정의 상전이온도까지 가열함으로써 위상차재료를 액정상태로 하고, 배향재 상에서 배향시킨다. 그리고, 배향상태가 된 위상차재료를 그대로 경화시켜, 위상차특성이 상이한 2종류의 위상차영역이 각각 복수, 규칙적으로 배치된, 패턴화 위상차재를 얻을 수 있다.In addition, when manufacturing the patterned retardation material used for 3D display, to the cured film formed by the above-mentioned method from the cured film composition of this embodiment from a predetermined reference|standard through the mask of a line and space pattern, for example, , +45 degrees of polarized UV exposure, and then, after removing the mask, polarized UV exposure is carried out in a -45 degree direction to obtain an alignment material in which two types of liquid crystal alignment regions having different orientation control directions of liquid crystals are formed. Then, after apply|coating the retardation material which consists of a polymeric liquid crystal solution, by heating to the phase transition temperature of a liquid crystal, the retardation material is made into a liquid crystal state, and it is oriented on an alignment material. And by hardening the phase difference material which became an orientation state as it is, the patterned phase difference material in which two types of phase difference areas from which phase difference characteristics differ were arrange|positioned regularly, respectively in multiple numbers can be obtained.
또한, 상기와 같이 하여 형성된, 본 실시의 형태의 배향재를 갖는 2매의 기판을 이용하고, 스페이서를 개재하여 양 기판 상의 배향재가 서로 마주하도록 붙인 후, 그들 기판 사이에 액정을 주입하여, 액정이 배향한 액정표시소자로 할 수도 있다.Further, using two substrates having the alignment material of the present embodiment formed as described above, and pasting the alignment materials on both substrates so that they face each other through a spacer, liquid crystal is injected between the substrates, and liquid crystal It can also be set as this aligned liquid crystal display element.
그에 따라, 본 실시의 형태의 경화막 형성 조성물은, 각종 위상차재(위상차필름)나 액정표시소자 등의 제조에 호적하게 이용할 수 있다.Thereby, the cured film formation composition of this embodiment can be used suitably for manufacture of various retardation materials (retardation film), a liquid crystal display element, etc.
실시예Example
이하, 본 발명의 실시예를 들어, 본 발명을 구체적으로 설명하나, 본 발명은 이것들로 한정하여 해석되는 것은 아니다.Hereinafter, the present invention will be specifically described by way of examples of the present invention, but the present invention is not limited to these and interpreted.
[실시예에서 이용하는 약기호][Abbreviations used in the examples]
이하의 실시예에서 이용하는 약기호의 의미는, 다음과 같다.The meanings of the abbreviations used in the following examples are as follows.
<원료><Raw material>
BMAA: N-부톡시메틸아크릴아미드BMAA: N-butoxymethylacrylamide
AIBN: α,α’-아조비스이소부티로니트릴AIBN: α,α′-azobisisobutyronitrile
<A성분><Component A>
MCA: 4-메톡시계피산MCA: 4-methoxycinnamic acid
[화학식 13][Formula 13]
<B성분><Component B>
PB-1PB-1
[화학식 14][Formula 14]
<C성분><C component>
HPC-SSL: 하이드록시프로필셀룰로오스HPC-SSL: Hydroxypropyl Cellulose
<D성분><Component D>
PTSA: p-톨루엔설폰산·일수화물PTSA: p-toluenesulfonic acid monohydrate
<E성분><E component>
KAYARAD PET-30KAYARAD PET-30
<용제><solvent>
실시예 및 비교예의 각 수지 조성물은 용제를 함유하고, 그 용제로서, 프로필렌글리콜모노메틸에테르(PM), 아세트산부틸(BA), 아세트산에틸(EA), 2-프로판올(IPA), 변성 에탄올(IPM: 에탄올/메탄올/IPA=85.5/1.1/13.4)을 이용하였다.Each resin composition of Examples and Comparative Examples contains a solvent, and as the solvent, propylene glycol monomethyl ether (PM), butyl acetate (BA), ethyl acetate (EA), 2-propanol (IPA), denatured ethanol (IPM) : ethanol/methanol/IPA=85.5/1.1/13.4) was used.
<중합체의 분자량의 측정><Measurement of molecular weight of polymer>
중합예에 있어서의 아크릴공중합체의 분자량은, 토소(주)사제 겔침투크로마토그래피(GPC)장치(HLC-8320), 토소(주)사제 컬럼사제 컬럼(TSKgel ALPHA4000, TSKgel ALPHA3000)을 이용하여 이하와 같이 하여 측정하였다.The molecular weight of the acrylic copolymer in the polymerization example is as follows using a gel permeation chromatography (GPC) apparatus (HLC-8320) manufactured by Tosoh Corporation, a column manufactured by Tosoh Corporation (TSKgel ALPHA4000, TSKgel ALPHA3000). It was measured in the same way.
한편, 하기의 수평균분자량(이하, Mn이라 칭한다.) 및 중량평균분자량(이하, Mw라 칭한다.)은, 폴리스티렌환산값으로 나타내었다.In addition, the following number average molecular weight (hereinafter referred to as Mn) and weight average molecular weight (hereinafter referred to as Mw) are expressed in terms of polystyrene.
컬럼온도: 40℃Column temperature: 40℃
용리액: 테트라하이드로푸란Eluent: tetrahydrofuran
유속: 1.0mL/분Flow rate: 1.0 mL/min
검량선작성용 표준샘플: 토소(주)사제 표준폴리스티렌(분자량 427,000, 190,000, 37,900, 18,100, 5,970, 2,420, 1,010)Standard sample for calibration curve: standard polystyrene manufactured by Toso Corporation (molecular weights 427,000, 190,000, 37,900, 18,100, 5,970, 2,420, 1,010)
<액정배향재의 점도 측정><Measurement of viscosity of liquid crystal alignment material>
장치: EMS-1000 교토전자공업주식회사제Apparatus: EMS-1000 made by Kyoto Electronics Industry Co., Ltd.
측정온도: 25℃Measuring temperature: 25℃
프로브사이즈: 2.0mmΦProbe size: 2.0mmΦ
회전수: 700rpmRPM: 700rpm
측정시간: 1초Measurement time: 1 second
<B성분의 합성><Synthesis of B component>
<중합예-1><Polymerization Example-1>
BMAA 100.0g, 중합촉매로서 AIBN 1.0g을 PM 193.5g에 용해하고, 80℃에서 20시간 반응시킴으로써 아크릴중합체용액을 얻었다. 얻어진 아크릴중합체의 Mn은 10,000, Mw는 23,000이었다. 아크릴중합체용액을 헥산 2000.0g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써, 중합체(PB-1)를 얻었다.An acrylic polymer solution was obtained by dissolving 100.0 g of BMAA and 1.0 g of AIBN as a polymerization catalyst in 193.5 g of PM, and reacting at 80° C. for 20 hours. Mn of the obtained acrylic polymer was 10,000, and Mw was 23,000. The acrylic polymer solution was gradually added dropwise to 2000.0 g of hexane to precipitate a solid, followed by filtration and drying under reduced pressure to obtain a polymer (PB-1).
<조제예 1><Preparation Example 1>
(A)성분으로서 MCA 0.054g, (B)성분으로서 중합예-1에서 얻은 PB-1 0.378g, (C)성분으로서 HPC-SSL 0.144g, (E)성분으로서 PET-30 0.144g(일본화약(주)사제)을 혼합하고, 이것에 용매로서의 PM 2.484g, BA 4.968g, IPA 0.828g을 첨가하여 1시간 교반하고, 육안으로 용해된 것을 확인하여 용액을 얻었다. 이어서, 이 얻어진 용액을 구명직경 0.2μm의 필터로 여과함으로써, 액정배향제(A-1)를 조제하였다.(A) 0.054 g of MCA as component, 0.378 g of PB-1 obtained in Polymerization Example-1 as (B) component, 0.144 g of HPC-SSL as (C) component, 0.144 g of PET-30 as (E) component (Nippon Chemicals) Co., Ltd.) was mixed, PM 2.484 g, BA 4.968 g, and IPA 0.828 g as solvents were added thereto, stirred for 1 hour, and dissolved visually to obtain a solution. Next, the liquid crystal aligning agent (A-1) was prepared by filtering this obtained solution with the filter with a hole diameter of 0.2 micrometer.
<조제예 2~6><Preparation Examples 2-6>
하기 표 1에 나타내는 종류 및 배합량의 각 성분을 이용한 것 이외는, 조제예 1과 동일하게 조작하여, (A-2)~(A-5), (B-1)을 조제하였다.Except having used each component of the kind and compounding quantity shown in following Table 1, it operated similarly to Preparation Example 1, and (A-2)-(A-5), (B-1) was prepared.
[표 1][Table 1]
<촉매용액의 조제><Preparation of catalyst solution>
<조제예 7><Preparation Example 7>
(D)성분으로서 PTSA 2.0g, 용매로서 PM 18.0g을 첨가하고, 1시간 교반하고, 육안으로 용해된 것을 확인하였다. 용액을 구명직경 0.2μm의 필터로 여과함으로써, 촉매용액(D-1)을 조제하였다.(D) As a component, PM 18.0g was added as 2.0 g of PTSA, and a solvent, it stirred for 1 hour, and it confirmed that it melt|dissolved visually. A catalyst solution (D-1) was prepared by filtering the solution through a filter having a hole diameter of 0.2 µm.
<경화막 형성 조성물(액정배향제)의 조제><Preparation of cured film forming composition (liquid crystal aligning agent)>
<실시예 1><Example 1>
조제예 1에서 얻어진 A-1을 2.00g, 조제예 7에서 얻어진 C-1을 0.06g, 희석용매로서 EA 0.60g을 첨가하고, 1분 교반함으로써 액정배향제AL-1을 얻었다.Liquid-crystal aligning agent AL-1 was obtained by adding EA 0.60g for 2.00 g of A-1 obtained in Preparation Example 1, 0.06 g for C-1 obtained by Preparation Example 7, and a dilution solvent, and stirring for 1 minute.
<실시예 2><Example 2>
조제예 2에서 얻어진 A-2를 이용한 것 이외는 실시예 1과 동일하게 조제를 행하여, 액정배향제AL-2를 얻었다.Except having used A-2 obtained in Preparation Example 2, it prepared similarly to Example 1, and obtained liquid-crystal aligning agent AL-2.
<실시예 3><Example 3>
조제예 3에서 얻어진 A-3을 이용한 것 이외는 실시예 1과 동일하게 조제를 행하여, 액정배향제AL-3을 얻었다.Except having used A-3 obtained by the preparation example 3, it prepared similarly to Example 1, and obtained liquid-crystal aligning agent AL-3.
<실시예 4><Example 4>
조제예 4에서 얻어진 A-4를 이용한 것 이외는 실시예 1과 동일하게 조제를 행하여, 액정배향제AL-4를 얻었다.Except having used A-4 obtained by the preparation example 4, it prepared similarly to Example 1, and obtained liquid-crystal aligning agent AL-4.
<실시예 5><Example 5>
조제예 5에서 얻어진 A-5를 이용한 것 이외는 실시예 1과 동일하게 조제를 행하여, 액정배향제AL-5를 얻었다.Except having used A-5 obtained in Preparation Example 5, it prepared similarly to Example 1, and obtained liquid-crystal aligning agent AL-5.
<비교예 1><Comparative Example 1>
조제예 6에서 얻어진 B-1을 이용한 것 이외는 실시예 1과 동일하게 조제를 행하여, 액정배향제BL-1을 얻었다.Except having used B-1 obtained by the preparation example 6, it prepared similarly to Example 1, and obtained liquid-crystal aligning agent BL-1.
<수평배향용 중합성 액정용액의 제작><Preparation of polymerizable liquid crystal solution for horizontal alignment>
<조제예 9><Preparation Example 9>
수평배향용 중합성 액정인 LC-242 1.57g(BASF사제), 광라디칼개시제인 Irgacure907 0.047g(BASF사제), 레벨링재인 BYK-361N 0.008g을 첨가하고, 추가로 용매로서 NMP 6.55g, 시클로펜탄온 9.83g을 첨가하고, 2시간 교반하고 육안으로 용해되어 있는 것을 확인하여, 9질량%의 중합성 액정용액LC-1을 얻었다.1.57 g of LC-242, a polymerizable liquid crystal for horizontal alignment (manufactured by BASF), 0.047 g of Irgacure907 (manufactured by BASF), a photo-radical initiator, and 0.008 g of BYK-361N, a leveling material, are added, and further as a solvent, NMP 6.55 g, cyclopentane 9.83 g of hot water was added, stirred for 2 hours, it was confirmed that it was melt|dissolving visually, and 9 mass % of polymerizable liquid crystal solution LC-1 was obtained.
<액정배향막의 형성 및 위상차필름의 제작><Formation of liquid crystal alignment film and production of retardation film>
<실시예 7><Example 7>
실시예 1에서 얻은 액정배향제(AL-1)를 기판으로서의 TAC필름 상에 바코터를 이용하여 Wet막두께 10μm으로 도포하였다. 열순환식 오븐 내에서 120℃에서 1분간의 가열건조를 행하여, 필름 상에 경화막을 형성하였다. 이어서, 이 경화막 표면에 313nm의 직선편광을 10mJ/cm2의 노광량으로 수직으로 조사하여, 액정배향막을 형성하였다. 수평배향용 중합성 액정용액LC-1을, 바코터를 이용하여 상기 액정배향막 상에 Wet막두께 34μm으로 도포하였다. 이어서, 오븐 내에서 120℃에서 2분간의 가열건조를 행한 후, 질소하, 365nm의 비편광을 500mJ/cm2의 노광량으로 수직으로 조사함으로써 중합성 액정을 경화시켜, 위상차필름을 제작하였다.The liquid crystal aligning agent (AL-1) obtained in Example 1 was applied to a wet film thickness of 10 μm using a bar coater on a TAC film as a substrate. Heat-drying was performed for 1 minute at 120 degreeC in the heat circulation type oven, and the cured film was formed on the film. Next, 313 nm linearly polarized light was vertically irradiated to the surface of this cured film with the exposure amount of 10 mJ/cm< 2 >, and the liquid crystal aligning film was formed. A polymerizable liquid crystal solution LC-1 for horizontal alignment was applied to the liquid crystal alignment layer with a wet film thickness of 34 μm using a bar coater. Then, after heating and drying at 120 ° C. for 2 minutes in an oven, the polymerizable liquid crystal was cured by vertically irradiating 365 nm of unpolarized light with an exposure amount of 500 mJ/cm 2 under nitrogen to prepare a retardation film.
<실시예 8~11, 비교예 3~4><Examples 8-11, Comparative Examples 3-4>
액정배향제로서 (AL-2)~(AL-5), (BL-1)을 이용하고, 실시예 7과 동일한 조작으로 위상차필름을 제작하였다.(AL-2) to (AL-5) and (BL-1) were used as liquid crystal aligning agents, and a retardation film was prepared in the same manner as in Example 7.
상기에서 제작한 각 위상차필름에 대하여, 하기 방법에 의해 평가를 행하였다. 그 평가결과를 표 2에 나타낸다.Each of the retardation films produced above was evaluated by the following method. Table 2 shows the evaluation results.
<배향성의 평가><Evaluation of orientation>
제작한 기판 상의 위상차필름을 한쌍의 편광판에 끼우고, 육안에 의해 크로스니콜하에서의 위상차특성의 발현상황을 관찰하였다. 위상차가 결함없이 발현되고 있는 것을 ○, 위상차가 발현되고 있지 않은 것을 ×로 하여 「배향성」의 란에 기재하였다.The retardation film on the produced substrate was sandwiched between a pair of polarizing plates, and the state of expression of the retardation characteristics under cross nicol was observed visually. It described in the column of "orientation property" by making into (circle) the thing in which the phase difference was expressed without a defect, and making x the thing in which the phase difference was not expressed.
<밀착성 평가><Adhesiveness evaluation>
제작한 기판 상의 위상차필름에 커터나이프를 이용하여 1mm 간격으로 기반목상으로 100칸의 칼집을 넣고, 점착테이프(니찌반(주)사제 셀로테이프(등록상표), 24mm 폭)를 강하게 압착시킨 후, 한번에 벗김으로써, 남은 격자의 수에 의해 평가하였다. 모두 남은 경우 ○, 일부가 벗겨진 경우 △, 모두 벗겨진 경우 ×로 하여 「밀착성」의 란에 기재하였다.Using a cutter knife, 100 cuts were made on the base wood at intervals of 1 mm on the retardation film on the produced substrate, and the adhesive tape (Cellotape (registered trademark) manufactured by Nichiban Co., Ltd., 24mm width) was strongly pressed. By peeling at a time, it was evaluated by the number of grids remaining. If all remained, ○, if some were peeled off, △, if all peeled off, as ×, and described in the "Adhesiveness" column.
[표 2][Table 2]
<액정배향제의 점도 평가><Evaluation of viscosity of liquid crystal aligning agent>
실시예 1~6에서 조제한 액정배향제AL-1~AL-6, 비교예 1~2에서 조제한 BL-1, BL-2에 대하여, 점도 측정을 행하였다. 실시예 1~6, 비교예 1~2에서 얻어진 액정배향제를 소정시간, 실온에서 보관하고, 동일하게 점도 측정을 행하여, 표 3에 기재한다.The viscosity was measured about liquid crystal aligning agent AL-1 - AL-6 prepared in Examples 1-6, and BL-1 and BL-2 prepared in Comparative Examples 1-2. The liquid crystal aligning agent obtained in Examples 1-6 and Comparative Examples 1-2 was stored at room temperature for a predetermined time, the viscosity was measured similarly, and it is described in Table 3.
[표 3][Table 3]
표 2의 결과로부터 배향성, 밀착성을 얻을 수 있는 액정배향제 조성인 것을 알 수 있는데, 표 3의 결과로부터, 용매 조성으로서 저급알코올을 첨가함으로써, 액정배향제 조제 후의 점도를 안정시키는 것이 가능해진다.Although it turns out that it is a liquid crystal aligning agent composition from which orientation and adhesiveness can be obtained from the result of Table 2, from the result of Table 3, it becomes possible to stabilize the viscosity after liquid crystal aligning agent preparation by adding a lower alcohol as a solvent composition.
본 발명에 따른 경화막 형성 조성물은, 액정표시소자의 액정배향막이나, 액정표시소자에 내부나 외부에 마련되는 광학이방성 필름을 형성하기 위한 배향재로서 매우 유용하며, 특히, 3D디스플레이의 패턴화 위상차재의 형성재료로서 호적하다. 나아가, 박막트랜지스터(TFT)형 액정표시소자나 유기EL소자 등의 각종 디스플레이에 있어서의 보호막, 평탄화막 및 절연막 등의 경화막을 형성하는 재료, 특히, TFT형 액정소자의 층간절연막, 컬러필터의 보호막 또는 유기EL소자의 절연막 등을 형성하는 재료로서도 호적하다.The cured film forming composition according to the present invention is very useful as an alignment material for forming a liquid crystal alignment film of a liquid crystal display device or an optically anisotropic film provided inside or outside a liquid crystal display device, and in particular, patterning retardation of 3D display It is suitable as a material for forming ash. Furthermore, materials for forming cured films such as protective films, planarization films, and insulating films in various displays such as thin film transistor (TFT) liquid crystal display elements and organic EL elements, in particular, interlayer insulating films of TFT-type liquid crystal elements, protective films of color filters Alternatively, it is also suitable as a material for forming an insulating film or the like of an organic EL device.
Claims (15)
(B)하이드록시기, 카르복실기 및 아미노기로부터 선택되는 1종 또는 2종 이상의 치환기를 갖는 친수성 폴리머,
(C)N-하이드록시메틸 화합물 또는 N-알콕시메틸(메트)아크릴아미드 화합물을 포함하는 모노머를 중합한 폴리머,
(D)가교촉매, 그리고,
탄소수 1~5의 알코올과, 탄소수 1~4의 지방산의 탄소수 1~4알킬에스테르와의 쌍방을 포함하는 용제를 함유하는 것을 특징으로 하는 경화막 형성 조성물.(A) a compound having any one substituent selected from a photo-alignment group, a hydroxyl group, a carboxyl group, and an amino group;
(B) a hydrophilic polymer having one or more substituents selected from a hydroxyl group, a carboxyl group and an amino group;
(C) a polymer obtained by polymerizing a monomer containing an N-hydroxymethyl compound or an N-alkoxymethyl (meth)acrylamide compound;
(D) a crosslinking catalyst, and
The cured film formation composition characterized by containing the solvent containing both C1-C5 alcohol and C1-C4 alkylester of a C1-C4 fatty acid.
(A)성분의 광배향성기가 광이량화 또는 광이성화하는 구조의 관능기인 것을 특징으로 하는 경화막 형성 조성물.The method of claim 1,
(A) The photo-alignment group of component is a functional group of the structure to photodimerize or photoisomerize, The cured film formation composition characterized by the above-mentioned.
(A)성분의 광배향성기가 신나모일기인 것을 특징으로 하는 경화막 형성 조성물.3. The method of claim 1 or 2,
(A) Photo-alignment group of component is cinnamoyl group, The cured film formation composition characterized by the above-mentioned.
(A)성분의 광배향성기가 아조벤젠구조의 기인 것을 특징으로 하는 경화막 형성 조성물.3. The method of claim 1 or 2,
(A) Photo-alignment group of component is group of azobenzene structure, The cured film formation composition characterized by the above-mentioned.
(A)성분이 2개 이상의 하이드록시기를 갖는 것을 특징으로 하는 경화막 형성 조성물.5. The method according to any one of claims 1 to 4,
(A) Component has 2 or more hydroxyl groups, The cured film formation composition characterized by the above-mentioned.
(B)성분이, 폴리에테르폴리올, 폴리에스테르폴리올, 폴리카보네이트폴리올 및 폴리카프로락톤폴리올로 이루어지는 군으로부터 선택된 적어도 1종의 폴리머인 것을 특징으로 하는 경화막 형성 조성물.6. The method according to any one of claims 1 to 5,
(B) Component is at least 1 sort(s) of polymer chosen from the group which consists of polyether polyol, polyester polyol, polycarbonate polyol, and polycaprolactone polyol, The cured film formation composition characterized by the above-mentioned.
(B)성분이 셀룰로오스 또는 그의 유도체인 것을 특징으로 하는 경화막 형성 조성물.6. The method according to any one of claims 1 to 5,
(B) Component is cellulose or its derivative(s), The cured film formation composition characterized by the above-mentioned.
(B)성분이, 폴리에틸렌글리콜에스테르기 및 탄소원자수 2 내지 5의 하이드록시알킬에스테르기 중 적어도 일방과, 카르복실기 및 페놀성 하이드록시기 중 적어도 일방을 갖는 아크릴중합체인 것을 특징으로 하는 경화막 형성 조성물.6. The method according to any one of claims 1 to 5,
(B) Component is an acrylic polymer having at least one of a polyethylene glycol ester group and a hydroxyalkyl ester group having 2 to 5 carbon atoms, and at least one of a carboxyl group and a phenolic hydroxy group, A cured film forming composition characterized in that .
(B)성분이, 하이드록시알킬기를 측쇄에 갖는 아크릴중합체인 것을 특징으로 하는 경화막 형성 조성물.6. The method according to any one of claims 1 to 5,
(B) Component is an acrylic polymer which has a hydroxyalkyl group in a side chain, The cured film formation composition characterized by the above-mentioned.
(E)성분으로서, 밀착향상성분을 추가로 함유하는 것을 특징으로 하는 경화막 형성 조성물.10. The method according to any one of claims 1 to 9,
(E) As a component, it further contains an adhesion improving component, The cured film formation composition characterized by the above-mentioned.
(A)성분과 (B)성분의 비율이 질량비로 5:95 내지 60:40인 것을 특징으로 하는 경화막 형성 조성물.11. The method according to any one of claims 1 to 10,
(A) Ratio of component and (B) component is 5:95-60:40 by mass ratio, The cured film formation composition characterized by the above-mentioned.
(A)성분의 화합물과 (B)성분의 폴리머의 합계량인 100질량부에 기초하여, 10질량부 내지 150질량부의 (C)성분을 함유하는 것을 특징으로 하는 경화막 형성 조성물.12. The method according to any one of claims 1 to 11,
(A) Based on 100 mass parts which is the total amount of the compound of component and (B) component, 10 mass parts - 150 mass parts (C)component are contained, The cured film formation composition characterized by the above-mentioned.
(A)성분의 화합물과 (B)성분의 폴리머의 합계량인 100질량부에 대해 0.01질량부 내지 10질량부의 (D)성분을 함유하는 경화막 형성 조성물.13. The method according to any one of claims 9 to 12,
(A) The cured film formation composition containing 0.01 mass parts - 10 mass parts (D)component with respect to 100 mass parts which are the total amounts of the compound of a component and the polymer of (B)component.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019212698 | 2019-11-25 | ||
JPJP-P-2019-212698 | 2019-11-25 | ||
PCT/JP2020/043626 WO2021106858A1 (en) | 2019-11-25 | 2020-11-24 | Cured film-forming composition, alignment material, and phase difference material |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220108097A true KR20220108097A (en) | 2022-08-02 |
Family
ID=76130250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020227021528A KR20220108097A (en) | 2019-11-25 | 2020-11-24 | Cured film forming composition, orientation material and retardation material |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPWO2021106858A1 (en) |
KR (1) | KR20220108097A (en) |
CN (1) | CN114746512B (en) |
TW (1) | TW202136422A (en) |
WO (1) | WO2021106858A1 (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS611342B2 (en) | 1979-06-13 | 1986-01-16 | Toppan Printing Co Ltd | |
JPH1068816A (en) | 1996-08-29 | 1998-03-10 | Sharp Corp | Phase difference plate and circularly polarizing plate |
JP2001517719A (en) | 1997-09-25 | 2001-10-09 | ロリク アーゲー | Photocrosslinkable polyimide |
JP2005049865A (en) | 2003-07-17 | 2005-02-24 | Arisawa Mfg Co Ltd | Manufacturing method of optical phase difference element |
JP2009058584A (en) | 2007-08-30 | 2009-03-19 | Jsr Corp | Liquid crystal aligning agent and method of forming liquid crystal alignment layer |
JP2009179563A (en) | 2008-01-29 | 2009-08-13 | Fujifilm Corp | Compound, liquid crystal composition and anisotropic material |
WO2011126022A1 (en) | 2010-04-08 | 2011-10-13 | 日産化学工業株式会社 | Composition forming heat-cured film having photo-alignment properties |
WO2014010688A1 (en) | 2012-07-12 | 2014-01-16 | 日産化学工業株式会社 | Composition for forming cured film, alignment material, and phase difference material |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5145660B2 (en) * | 2005-10-18 | 2013-02-20 | Dic株式会社 | Composition for photo-alignment film, method for producing photo-alignment film, optical anisotropic body using the same, optical element, and method for producing the same |
JP4816003B2 (en) * | 2005-10-28 | 2011-11-16 | Dic株式会社 | Composition for photo-alignment film, method for producing photo-alignment film, optical anisotropic body using the same, optical element, and method for producing the same |
JP5678824B2 (en) * | 2011-01-05 | 2015-03-04 | Jsr株式会社 | Liquid crystal aligning agent, liquid crystal aligning film, retardation film production method, retardation film and liquid crystal display element |
CN107463066B (en) * | 2011-10-11 | 2020-10-30 | 日产化学工业株式会社 | Cured film-forming composition, alignment material, and phase difference material |
JP6086115B2 (en) * | 2012-03-28 | 2017-03-01 | 日産化学工業株式会社 | Cured film forming composition, alignment material and retardation material |
KR102042441B1 (en) * | 2012-06-20 | 2019-11-08 | 닛산 가가쿠 가부시키가이샤 | Novel polymerizable compound and method for producing same |
JP5994564B2 (en) * | 2012-10-22 | 2016-09-21 | Jnc株式会社 | Thermosetting composition having photo-alignment |
WO2014171376A1 (en) * | 2013-04-16 | 2014-10-23 | 日産化学工業株式会社 | Cured film-forming composition, alignment material, and phase difference material |
CN110408159B (en) * | 2014-06-30 | 2022-02-08 | 日产化学工业株式会社 | Composition for forming cured film, alignment material, and phase difference material |
JP6572532B2 (en) * | 2014-10-15 | 2019-09-11 | 東ソー株式会社 | Resin composition and optical compensation film using the same |
JP6048556B2 (en) * | 2014-11-26 | 2016-12-21 | 東ソー株式会社 | Resin composition and optical compensation film using the same |
WO2016143860A1 (en) * | 2015-03-11 | 2016-09-15 | 日産化学工業株式会社 | Cured film-forming composition, alignment material and the phase difference material |
KR102587587B1 (en) * | 2015-03-11 | 2023-10-11 | 닛산 가가쿠 가부시키가이샤 | Cured film forming composition, orientation material and phase difference material |
JP6648462B2 (en) * | 2015-09-30 | 2020-02-14 | 大日本印刷株式会社 | Thermosetting composition having photo-alignment property, alignment layer, substrate with alignment layer and method for manufacturing the same, retardation plate and method for manufacturing the same |
WO2019078201A1 (en) * | 2017-10-16 | 2019-04-25 | 日産化学株式会社 | Cured-film-forming composition, orienting material, and phase contrast material |
-
2020
- 2020-11-24 CN CN202080081627.8A patent/CN114746512B/en active Active
- 2020-11-24 JP JP2021561416A patent/JPWO2021106858A1/ja active Pending
- 2020-11-24 TW TW109141146A patent/TW202136422A/en unknown
- 2020-11-24 KR KR1020227021528A patent/KR20220108097A/en active Search and Examination
- 2020-11-24 WO PCT/JP2020/043626 patent/WO2021106858A1/en active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS611342B2 (en) | 1979-06-13 | 1986-01-16 | Toppan Printing Co Ltd | |
JPH1068816A (en) | 1996-08-29 | 1998-03-10 | Sharp Corp | Phase difference plate and circularly polarizing plate |
JP2001517719A (en) | 1997-09-25 | 2001-10-09 | ロリク アーゲー | Photocrosslinkable polyimide |
JP2005049865A (en) | 2003-07-17 | 2005-02-24 | Arisawa Mfg Co Ltd | Manufacturing method of optical phase difference element |
JP2009058584A (en) | 2007-08-30 | 2009-03-19 | Jsr Corp | Liquid crystal aligning agent and method of forming liquid crystal alignment layer |
JP2009179563A (en) | 2008-01-29 | 2009-08-13 | Fujifilm Corp | Compound, liquid crystal composition and anisotropic material |
WO2011126022A1 (en) | 2010-04-08 | 2011-10-13 | 日産化学工業株式会社 | Composition forming heat-cured film having photo-alignment properties |
WO2014010688A1 (en) | 2012-07-12 | 2014-01-16 | 日産化学工業株式会社 | Composition for forming cured film, alignment material, and phase difference material |
Also Published As
Publication number | Publication date |
---|---|
CN114746512B (en) | 2023-09-22 |
WO2021106858A1 (en) | 2021-06-03 |
CN114746512A (en) | 2022-07-12 |
JPWO2021106858A1 (en) | 2021-06-03 |
TW202136422A (en) | 2021-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI633148B (en) | Cured film forming composition, alignment material and retardation material | |
KR101957430B1 (en) | Cured film formation composition, orientation material, and phase difference material | |
JP6274442B2 (en) | Cured film forming composition, alignment material and retardation material | |
JP6090601B2 (en) | Cured film forming composition, alignment material and retardation material | |
JP6260790B2 (en) | Alignment material manufacturing method, alignment material, retardation material manufacturing method, and retardation material | |
CN110408159B (en) | Composition for forming cured film, alignment material, and phase difference material | |
TWI627214B (en) | Cured film forming composition, alignment material and retardation material | |
TWI623572B (en) | Cured film forming composition, alignment material and retardation material | |
KR20200135968A (en) | Cured film forming composition, alignment material, and retardation material | |
CN112041713B (en) | Composition for forming cured film, alignment material, and retardation material | |
CN114746512B (en) | Composition for forming cured film, alignment material, and retardation material | |
WO2023204280A1 (en) | Cured film-forming composition, alignment material, and retardation material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination |